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Porcine reproductive and respiratory syndrome virus (PRRSV) causes late-term 
abortion in sows and pneumonia in growing piglets. PRRSV evades the host immune 
response by several mechanisms, including the modulation of cytokine secretions in 
infected pigs, which is the subject of this dissertation. Particularly, PRRSV reduces the 
secretion of the pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α) but 
increases the secretion of the anti-inflammatory cytokine interleukin-10 (IL-10). The 
latter effect, however, is PRRSV strain-specific. In this dissertation, we have examined 
mechanisms by which PRRSV regulates TNF-α and IL-10 expressions. The pathogenic 
strain FL12, derived from a PRRSV infectious clone, consistently suppressed TNF-α but 
failed to induce IL-10 in infected swine cells. In addition, no significant IL-10 production 
takes place in pig tissues following infection with vFL12. Using a TNF-α promoter-
reporter gene construct, we demonstrated that the viral non-structural proteins, Nsp1α and 
Nsp1β reduce the TNF-α promoter activity in transiently transfected cells, mainly by 
inhibiting the cellular transcription factors Nuclear Factor-κB (NF-κB) and Specificity 
Protein 1 (Sp1) respectively. Furthermore, screening of Nsp1α mutant constructs revealed 
 that five amino acid residues (Gly90, Asn91, Arg97, Arg100, and Arg124) are important 
for inhibiting the TNF-α promoter activity. Nsp1α also reduced TNF-α protein levels in 
an in vitro translation assay, and Gly90 was important for this activity. Screening of 
Nsp1β mutant constructs showed that multiple amino acid stretches in all domains are 
important for inhibiting the TNF-α promoter activity. We obtained two mutant vFL12 
strains with substitutions at Nsp1αGly90 and Nsp1β70SMVRE74 positions. Both mutant 
viruses increased TNF-α mRNA levels at early times after infection when compared to 
parental vFL12 strain in infected macrophages. However, only Nsp1α mutant virus 
induced higher TNF-α protein levels when compared to vFL12 in infected macrophage 
cultures. Moreover, Nsp1β mutant virus was attenuated in infected pigs. In summary, we 
have identified proteins that regulate the expression of TNF-α. These results may be 
useful for designing novel prophylactics and therapeutics for PRRSV. 
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CHAPTER I 
Literature Review 
1. Introduction  
 Porcine reproductive and respiratory syndrome (PRRS) is a disease affecting 
swine, which is characterized by reproductive failure in pregnant sows and pneumonia in 
growing pigs. The causative agent, porcine reproductive and respiratory syndrome virus 
(PRRSV) belongs to the family Arteriviridae classified under the order Nidovirales (193). 
The virus is classified into two genotypes, European (genotype I) and North American 
(Genotype II) based on genetic relatedness (111). Within each genotype, several 
genetically distinct strains are circulating in the swine populations temporally and 
geographically (153, 162). 
  Since its identification in the late 1980s (77), the control of PRRS in the field was 
unsuccessful due to the lack of effective vaccines. At present, the virus is endemic 
throughout the world and is an economically important pathogen of swine. Current live 
attenuated vaccine strains do not provide complete protection against heterologous strains 
and may revert back to virulence (91, 128).  Even with the availability of reverse genetics 
systems for PRRSV (113, 114, 126, 178), the knowledge about the basis of attenuation, 
means to increase heterologous protection, means to avoid immune evasion mechanisms 
are needed to develop safe, effective, live attenuated PRRSV vaccines. In this dissertation, 
we aimed to understand and explore means to attenuate PRRSV by knocking down 
cytokine evasion mechanisms, which could lead to better vaccine development in the 
future.  
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2. Pathogenesis of PRRS  
2.1. Clinical signs  
 PRRS is characterized by two groups of clinical syndromes, reproductive and 
respiratory. The reproductive syndrome is mainly characterized by reproductive failure in 
pregnant gilts and sows during the third trimester of pregnancy (29, 69). The reproductive 
clinical signs include pre-mature farrowing with mummified fetuses and still born piglets 
(69). The respiratory clinical signs are more prominent in infected neonatal piglets and 
nursery pigs (143). They include dyspnea and tachypnea (69, 142). Type I genotype 
strains predominantly causes reproductive disease in pregnant sows. Type II genotype 
strains generally cause both reproductive as well as respiratory diseases in pregnant sows 
and young piglets respectively (122). Other atypical clinical signs of PRRS include fever, 
lethargy, inappetence, rough hair coat, cutaneous erythema, blue discoloration of ears, 
conjunctivitis, periorbital edema, and subcutaneous edema (141). 
2.2. Mortality and morbidity  
 The mortality and morbidity rate of infected pigs is inversely correlated with age 
but directly correlated with the severity of disease complication by secondary infections. 
The mortality rate in neonatal pre-weaning pigs infected with PRRSV in utero or 
perinatally may reach 100% (69, 143). The mortality rate in weaned pigs infected with 
PRRSV usually ranges from 1-2% and increases up to 15% if concurrent bacterial 
infections occur (143). However, the mortality rate is usually low (1-4%) in infected 
sows (69).  
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2.3. Transmission and sites of replication  
 Direct contact between PRRSV-infected pigs and uninfected pigs is a major route 
of transmission (141). Upon exposure to infectious body fluids (141), virus may initially 
replicate in resident macrophages present in mucosal surfaces. The virus then spreads 
systemically to lungs, several secondary lymphoid tissues, endometrium, fetal 
implantation tissues and fetus (49, 75, 137). In infected young pigs, virus replicates 
primarily in a subpopulation of alveolar macrophages in lungs (49), however, in fetuses, 
thymus has become a primary site of replication (144).  
 Viral replication in various tissues establishes a viremic period that starts as early 
as 24 h (h) after infection, peaks at 7-14 days, and lasts up to one month, especially in 
young pigs (49, 142, 143). After this viremic period, virus establishes a persistent phase 
lasting at least 150 days post-infection due to continued low-level replication in lymphoid 
tissues such as tonsils and lymph nodes (3, 196). Persistently infected pigs also remain an 
important source of transmission within a herd for at least 86 days post-infection (11). 
They ultimately clear virus from infected tissues after several months of infection (3).  
2.4. Lesions  
 Gross lesions include inconsistent diffuse tan consolidated lesions in affected 
lobes of lungs and prominent enlargement of affected lymph nodes especially in growing 
pigs (32, 46). Microscopically, interstitial pneumonia in lungs is common due to 
inflammation caused by PRRS virus (32, 142). Lung microscopic lesions include necrotic 
cell debris in alveoli, thickening of alveolar wall due to infiltration of macrophages and 
lymphocytes (142). In lymph nodes, germinal center necrosis, germinal center 
hyperplasia and hypertrophy, polycystic appearance are major lesions observed during 
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field and experimental PRRSV infections (142). Apoptosis of infected macrophages 
including bystander non-infected macrophages, and infiltration of inflammatory cells into 
infected tissues are major causes of lesions observed during PRRS pathogenesis (142, 
156).      
3. Molecular biology of PRRSV  
3.1. Structure of virion 
 PRRSV virion is composed of a nucleocapsid core surrounded by an envelope. 
The nucleocapsid core is a double layered hollow core (161) comprised of a RNA 
genome encapsidated with dimeric forms of the nucleocapsid (N) protein (161). The 
genome is a single-stranded, positive-sense, capped and poly-adenylated RNA of 
approximately 15Kb. The N protein interacts with the RNA genome through a N-terminal 
domain that is rich in positively charged amino acids, and dimerizes through a C-terminal 
domain (161). The envelope is a bi-layered lipid membrane containing six membrane 
proteins that interact with host receptors, nucleocapsid proteins, and is involved with 
virus uncoating.  
 The envelope has six structural proteins, GP2, E, GP3, GP4, GP5, and M. GP2, 
GP3, and GP4 that together form a hetero-trimeric complex that appear as a protruding 
structure on the surface of PRRSV virion (161, 197). GP5 and M together form a hetero-
dimeric complex that contribute to the smooth structure of the virion surface (109). These 
two proteins have relatively small ectodomains covalently linked by a disulfide bond 
(161). GP5 and M also have large endodomains that weakly interact with the 
nucleocapsid (161, 197). The GP2-GP3-GP4 heterotrimer also interacts with the E 
protein (197). GP5-M and GP2-GP3-GP4-E complexes form major and minor 
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components of the envelope respectively. All GP2-5 proteins are N-glycosylated proteins 
with at least two complex N-glycans that usually contain terminal sialic acid residues (37, 
38).  
3.2. Viral entry and uncoating          
 PRRSV virion initially attaches to heparin sulfate molecules on the cell 
surface through interactions with the M protein (41). Following this attachment, the virus 
interacts with another receptor, sialoadhesin through terminal sialic acid residues present 
in its glycoproteins (39, 40). This interaction leads to clathrin-mediated endocytosis 
which puts the PRRSV virion in acidified late endosome (86). Further, the interaction of 
PRRSV with CD163 receptor through both GP2 and GP4 is essential for virus uncoating 
in endosomes (36, 182).  The virus uncoating also requires the E protein which may form 
an H+ ion channel to help in disrupting the nucleocapsid interactions with the envelope 
(98). Upon virus uncoating, the free nucleocapsid is released into the cytoplasm.  
3.3. Viral replication, transcription, and assembly 
 When naked or encapsidated RNA genome reaches the cytoplasm, it is considered 
to be infectious and primary translation starts. The RNA genome contains nine open 
reading frames, ORF1a, ORF1b, ORF2-7, and ORF5a (73). During primary translation, 
ORF1a and ORF1b are translated through ribosomal scanning and ribosomal frame shift 
mechanisms respectively. ORF1a and ORF1b produce two polyproteins, pp1a and pp1b 
of approximately 2397 and 3854 amino acids respectively. The pp1a and pp1b are 
proteolytically processed into 14 non-structural proteins, Nsps 1α, 1β, 2-6, 7α-7β, 8-12 
(87, 112, 180). Nsp1α, Nsp1β, Nsp2, and Nsp4 are cysteine/serine proteases that auto-
cleave themselves from the poly-protein (87, 112). However, other ORF1 proteins are 
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processed by Nsp4, a serine protease (112, 180). The viral replication complex assembles 
on a endomembrane scaffold created by Nsp2 and other ORF1a proteins (181).  The main 
component of the replication complex is Nsp9 which is a RNA dependent RNA 
polymerase (112). The replication complex also contains Nsp11 and Nsp12 (112). The 
replicase complex amplifies genomes/anti-genomes in double membrane vesicles (135).  
 The replicase complex also produces six sub-genomic mRNAs using six anti-
genome templates synthesized from 20% of the genome located at the 3’ end (43). Each 
of these sub-genomic mRNAs produces one or two structural proteins that become part of 
virion (73, 199) .  
 Virion assembly occurs in the endoplasmic reticulum and/or Golgi complex 
through budding of nucleocapsids into their lumen. During budding, the envelope 
formation around the nucleocapsid is primarily determined by GP5-M heterodimers that 
reside in intracellular membranes (197). GP5-M complexes weakly interact with 
nucleocapsid that leave a significant gap between the envelope and nucleocapsid (161). 
GP2-GP3-GP4-E complexes are recruited to virion envelope through interactions 
between GP4 and GP5 (36). After budding, packaged virions are loaded in intracellular 
vesicles and transported to the cell surface for progeny virus release.  
4. Cell tropism of PRRSV 
4.4.1. Macrophages  
PRRSV has a restricted cell tropism, infecting cells of myeloid lineage that 
include differentiating monocytes, fully differentiated macrophages, immature and 
mature dendritic cells (48, 55, 190). In pigs, PRRSV-infected cells are found in clusters 
and are not always located in close proximity to microscopic lesions (97). They are found 
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in lungs, tonsils, spleens, testes, ovaries, and lymph nodes such as retropharyngeal, 
bronchial, sternal, thoracic, aortic, inguinal, and mesenteric lymph nodes, (49, 119, 168, 
169). In lungs, alveolar macrophages become predominant target for replication although 
PRRSV replicates in septal macrophages, intravascular macrophages (49, 61, 174). Only 
2% of alveolar macrophages are infected during acute infection of lungs (49). 
Macrophages present in endometrium and fetal placental tissues are also highly 
permissive for PRRSV, which may contribute to virus spread to the fetus (75). However, 
peritoneal macrophages are resistant to PRRSV replication because they lack a cellular 
receptor for PRRSV (48). Monocytes that are cultivated in vitro become permissive after 
one day of culture which correlates with increase in CD163 expression (134). 
4.4.2. Dendritic cells  
Dendritic cell populations have differential susceptibility to PRRSV infection. 
Lung dendritic cells are not permissive for PRRSV replication (106). However, the 
dendritic cells grown in vitro such as monocyte-derived dendritic cells and bone marrow-
derived dendritic cells are highly susceptible to PRRSV infection (22, 55, 190). The level 
of infection is independent of the maturation status of dendritic cells (55, 190). In 
addition to macrophages and dendritic cells, PRRSV can infect testicular germ cells (168). 
4.4.3. Host factors required for PRRSV infection   
In addition to cellular receptors for PRRSV, other host factors determine tropism 
for PRRSV. For instance, in permissive MARC-145 cells, vimentin binds to the 
nucleocapsid protein of PRRSV which may be required for the subsequent nucleocapsid 
transport within cytosol through cytoskeletal filaments (81). Similarly, CD151, a 
tetraspanin, is required for permissivity in MARC-145 cells (152). In MARC-145 cells, 
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direct cell-to-cell transmission of PRRSV is also observed in a cytoskeleton-dependent 
manner (18). 
5. Innate immune responses during PRRSV infection 
 PRRSV suppresses innate immune responses in infected alveolar macrophages, 
pulmonary intravascular macrophages and plasmacytoid dendritic cells (1, 20, 102).  
PRRSV inhibits several innate signaling pathways such as type I interferon (10), tumor 
necrosis factor-α (164), and bactericidal pathways (174). In natural killer cells (NK cells) 
of infected swine, PRRSV also inhibits cell-mediated cytotoxicity (74). 
5.1. Type I Interferon responses against PRRSV infection 
Exogenous IFN-α in the supernatant of infected alveolar macrophages inhibits 
PRRSV replication (17). To efficiently replicate in vivo, PRRSV actively suppresses type 
I interferons such as interferon-β and interferon-α in infected macrophages (1, 10). 
Furthermore, PRRSV interferes with type I interferon production in non-permissive 
plasmacytoid dendritic cells (19, 20). Reduced IFN levels in PRRSV-infected lungs 
exacerbate pneumonia caused by porcine respiratory coronavirus (PRCV) super-infection 
(74). When PRCV infected pigs were super-infected with PRRSV, PRCV induced IFN-α 
could reduce PRRSV viral titers in the lungs (17). Detailed studies revealed that PRRSV 
non-structural proteins inhibit type I interferon induction and interferon signaling in 
infected macrophages (10). However, PRRSV structural proteins may contribute to the 
suppression of type I interferon induction in non-permissive plasmacytoid dendritic cells 
(20).  
PRRSV non-structural proteins, Nsp1α, Nsp1β, and Nsp11, prevent interferon 
regulatory factor-3 (IRF-3) activation that is essential for type I interferon induction (10). 
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Moreover, another non-structural protein, Nsp2 inhibits IFN-β synthesis through its 
ovarian tumor (OTU) domain that deubiquitinates IκB thereby preventing NF-κB 
activation (167). Interestingly, PRRSV also suppresses expression of toll-like receptors 
(TLR7, TLR3), which trigger IRF-3 and NF-κB activation (24). Additionally, PRRSV 
blocks the downstream IFN signaling pathway to inhibit the amplification of IFN 
responses (133). For example, Nsp1β blocks the nuclear translocation of signal 
transducer and activator of transcription 1/2 (STAT1/2) thus inhibiting the expression of 
interferon-stimulated genes such as ISG15 and ISG56 (133).   
Structural proteins on the surface of PRRSV virion particles also interact with an 
unknown molecule on the surface of plasmacytoid dendritic cells to inhibit type I 
interferon induction (20). Furthermore, structural proteins down modulate the constitutive 
interferon regulatory factor-7 (IRF-7) expression in plasmacytoid dendritic cells by 
inhibiting the STAT1 transcription factor (20). 
5.2. TNF-α response against PRRSV infection 
PRRSV suppresses the inflammatory cytokine, tumor necrosis factor-alpha (TNF-
α) in infected macrophages and plasmacytoid dendritic cells (19, 102). PRRSV Nsp1α 
and Nsp1β inhibit TNF-α expression at its promoter level by suppressing NF-κB 
activation and Sp1 trans-activation, respectively (164). In addition, PRRSV may also 
inhibit downstream TNF-α signaling because over-expressed Nsp1α suppresses NF-κB 
nuclear translocation in response to exogenous TNF-α (159). Exogenous addition of 
TNF-α was found to decrease viral titers of infected alveolar macrophages (102) 
suggesting TNF-α has anti-viral effects directed against PRRSV. 
 
10 
5.3. Modulation of macrophages survival and innate function by PRRSV 
    PRRSV establishes an anti-apoptotic state in infected alveolar macrophages 
during early stages of infection (33, 58, 200). However, it induces apoptosis in infected 
alveolar macrophages during later stages of infection (33). During in vivo infection, the 
virus induces apoptosis predominantly in by-stander non-infected macrophages/ 
monocytes and infiltrated T cells (75, 92).  
Besides its effect on the survival of alveolar macrophages, PRRSV also decreases 
their ability to kill and remove opportunistic secondary bacterial infections during in vivo 
infections (158, 174). The virus significantly decreases the levels of superoxide anion and 
myeloperoxidase-H2O2-halide product in infected alveolar and intravascular macrophages 
(174). In addition to impaired bactericidal activity, macrophages also showed decreased 
phagocytosis of bacteria such as Hemophilus parasuis during later stages of PRRSV 
infection (158). In summary, PRRSV may compromise the innate immune functions of 
alveolar macrophages during secondary bacterial co-infections. 
PRRSV induces IFN-γ serum levels from day 1 up to 22 days post-infection in 
infected pigs (194). The cellular source of this early IFN-γ production is believed to be 
from activated NK cells (194). Because exogenous IFN-γ has consistently shown anti-
viral effects in PRRSV-infected macrophage cultures (8), it is logical to suggest that 
increases in IFN-γ serum levels during early phases of an in vivo infection (194) may 
have anti-viral effects on PRRSV replication in macrophages. Even though there is an 
influx of NK cells into PRRSV-infected tissues (148), their effector functions including 
cytotoxicity, are severely impaired in infected pigs (74). Suppression of NK cell 
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functions is active rather than passive because PRCV super-infection could not activate 
NK cells in the presence of PRRSV in lungs (74). 
In conclusion, PRRSV interferes with innate immune responses during in vivo 
infection which might affect the induction of adaptive immune responses: in particular 
cell-mediated immune (CMI) responses. 
6. Adaptive immune responses during PRRSV infection 
6.1. Humoral immune responses against PRRSV 
PRRSV can induce specific B cell effector and memory responses during in vivo 
infection (119). Consequently, PRRSV induces a robust antibody response as early as 7 
days post-infection (205). The PRRSV-specific antibody responses were detected for at 
least 604 days post-infection (93). But, the antibody responses are heavily skewed 
towards non-neutralizing antibodies during 7-21 days post-infection (205). In contrast, 
the neutralizing antibody responses generally appear late after resolving viremia (205) 
and, are variable depending on the viral strain (188). Fewer reports have suggested that 
PRRSV may induce polyclonal activation of B cells non-specifically in tonsils from three 
days post-infection (95). 
The non-neutralizing antibody responses are postulated to enhance PRRSV 
infection during viremic period (104). In spite of their late appearance post-infection and 
their lack of participation with respect to viral clearance, neutralizing antibodies may play 
a significant role in preventing an infection (105). This concept was confirmed by passive 
transfer of neutralizing antibodies prior to infection, thus providing sterilizing immunity 
in pregnant sows and young pigs if the titer is at least 1: 8 to 1:16 (104, 105). However, 
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the presence of neutralizing antibodies in serum does not prevent virus replication in 
infected tissues and also does not prevent virus spread to exposed animals (104).  
The recall anamnestic responses against homologous PRRSV challenge are due to 
the induction of memory B cell responses in secondary lymphoid organs but not in 
Peyer’s patches of small intestine or bone marrow (119). Memory B cell responses are 
predominantly directed against proteins that induce non-neutralizing antibodies such as 
Nsp2 and N rather than those that induce neutralizing antibodies such as GP5 (119).  As 
expected, plasma cell responses are primarily directed towards Nsp2 and N proteins 
during secondary antigen exposure (119). Nevertheless, the anamnestic responses against 
a heterologous PRRSV challenge have been described as shorter and provide incomplete 
protection (94). Interestingly, antibody-dependent depletion of MHC II+ cells and CD4+ 
cells from infected peripheral blood mononuclear cells (PBMCs) were sufficient to 
decrease the PRRSV-specific T cell proliferative responses by about 80% (7).  
Neutralizing antibodies are induced by GP2, GP3, GP4, GP5, and M proteins (116, 
129, 186, 187, 202). GP3 and GP5 neutralizing epitopes are shielded from induction of 
neutralization antibodies by N-glycans (5, 187).  GP5 possess a major neutralizing 
epitope in its ectodomain whose immunogenicity is masked by an adjacent non-
neutralizing decoy epitope (129, 136).   
Overall, PRRSV induces robust humoral immune responses: but effector and 
memory B cell responses are skewed toward non-neutralizing antibodies. Infection averts 
the development of neutralizing antibodies beyond the viremic phase, which is relatively 
weak and protective only against challenges with homologous or closely related strains. 
But challenges with heterologous strains only protects well to fraction of the animals. 
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6.2. Cell-mediated immune responses against PRRSV 
PRRSV interferes with CMI responses, which allow a long-lived persistent 
infection (96). In addition to serum neutralizing antibodies, IFN-γ-specific T cell 
responses play a significant role in PRRSV clearance (6). The IFN-γ-specific T cell 
responses can be detected as early as 14 days post-infection (dpi) (6). After 8-10 weeks 
after infection, IFN-γ-specific T cell responses increases until 48 weeks, remains stable 
until 690 days post-infection (110). This gradual development of IFN-γ-specific T cell 
responses is sub-optimal when compared to pseudorabies viral infections (110). 
Nevertheless, the IFN-γ-specific T cell responses are partly responsible for viral 
clearance from acutely infected lungs including viremia but are ineffective in clearing 
virus from persistently infected tissues (96, 148).  
In PBMCs from infected pigs, T cell proliferative responses are mainly 
contributed by CD4-CD8+ (high) and CD4+CD8+ cells (62, 96). CD-CD8+ (high) cells 
and CD4+CD8+ cells represent the effector cytotoxic T cells and memory T cells in 
swine respectively (123, 208). Specifically, the drop in viremia after 3-4 weeks of 
PRRSV infection is correlated with enhanced CD4-CD8+ (high) cells in PBMCs (62, 96). 
In contrast, in acutely infected lungs, CD4-CD8+ cells but not CD4+CD8+ cells are 
predominantly infiltrating after 7 days post-infection (148).  
The CD4-CD8+ T cell infiltration into lungs may be due to selective chemotactic 
signals and their kinetics are correlated with decreases in cell-associated PRRSV in lungs 
(148). CD8+ cytotoxic T lymphocytes are juxta-positioned next to PRRSV-infected cells 
in lungs as judged by immunohistochemical staining (176). However, the impaired CD2+ 
CD8+ (high) T cell responses in mediastinal lymph nodes and tonsils during PRRSV 
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persistent infection may favor viral persistence in those tissues (96). This is consistent 
with the finding that CD3+CD8+(high) cells from PRRSV-infected pigs do not exhibit 
cytotoxicity towards PRRSV-infected alveolar macrophages as detected by in vitro CTL 
assay (34).   
T cell responses to mitogens such as Concavalin A, and Phytohemagglutinin 
(PHA) were transiently impaired in blood and lymphoid organs during PRRSV 
persistence (96). This non-specific T cell suppression may be due to the induction of Th3 
regulatory cells in response to PRRSV-infected dendritic cells (155). These PRRSV-
induced Th3 regulatory cells are phenotypically characterized as Foxp3+CD25+ T cells 
that can suppress PHA-stimulated PBMCs (155). Overall, these studies suggest that 
functional impairment of CD8+ (high) T cells may be the explanation for ineffective 
PRRSV clearance in infected pigs. 
Apart from αβ TCR+ T-lymphocytes, pigs also contain a high percentage of γδ 
TCR+ T-lymphocytes in blood that contributes to specific adaptive responses against 
various pathogens (127). Another report suggests that γδ TCR+ T-lymphocytes cells 
possess constitutive natural killer activity in pigs (103). Interestingly, γδ TCR+ T-
lymphocytes also expand in response to PRRSV in the peripheral blood during 14 to 70 
days post-infection and are capable of inducing IFN-γ in response to antigen stimulation 
(127). Most of the responding γδ TCR+ T-lymphocytes are positive for the CD8 marker 
(103). The role of γδ TCR+ T-lymphocytes in clearing virus from blood is not fully 
understood (127).  
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 Functionally, the expanded CD8+ cells from PRRSV-infected pigs that comprise 
CD8(high), CD4+CD8+, γδ TCR+CD8+ cells have moderately increased cytotoxic 
activity from 15% to 35% towards a tumor cell line in an in vitro cytotoxicity assay (103).  
7. Cytokine responses during PRRSV infection 
  PRRSV generally suppress induction of many pro-inflammatory, anti-viral and T 
cell immunomodulatory cytokines in infected macrophages and dendritic cells. It also up 
regulates immunosuppressive cytokines such as TGF-β and IL-10: but this is dependent 
on the viral genotype and strains. The presence of several exogenous anti-viral cytokines 
in the supernatant of infected macrophages or MARC-145 cells can inhibit PRRSV 
replication.   
7.1. Modulation of pro-inflammatory cytokines by PRRSV 
PRRSV weakly induces pro-inflammatory cytokines both in vitro and in vivo. In 
infected pigs, IL-1β and IL-8 levels are increased during acute replication but not viral 
persistence (107). Interestingly, PRRSV increases IL-8 protein, but not its mRNA levels 
(173). In the majority of infected pigs, PRRSV consistently induces IL-1β with a similar 
kinetics following viremia (92, 184). However, infection increases TNF-α slightly at 14 
days post-infection (dpi) in some infected pigs (92, 184). In contrast, significant IL-6 
induction was observed in PRRSV-infected pigs in vivo (173, 184). In infected fetuses, 
there were marked up regulation of TNF-α and IFN-γ in lungs and serum both at mRNA 
and protein levels (144). Two-weeks old in utero infected piglets exhibited increased IL-
12 and IFN-γ mRNAs (72). However, four-weeks old in utero infected piglets have 
increased TNF-α and IL-8 mRNA levels (72). PRRSV-infected pigs consistently up 
regulate IL-12p40 mRNA levels in PBMCs and PAMs during acute and persistent phases 
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of infection (173). There is a correlation between IL-12p40 levels and IFN-γ levels in 
infected pigs (61). 
PRRSV also augments the production of all pro-inflammatory cytokines such as 
TNF-α, IL-1, IL-6, IL-8 in pigs co-infected with Mycoplasma hyopneumoniae or treated 
with bacterial endotoxin (173, 184). These pro-inflammatory responses are due to CD14 
and LPS receptor up regulation on monocytes infiltrating into the lungs (183). PRRSV 
also stimulates pro-inflammatory chemokine: Regulated upon Activation Normal T-cell 
Expressed and Secreted (RANTES) in TLR-MyD88-dependent manner (191). In contrast, 
PRRSV suppresses the inflammatory chemokine: macrophage inflammatory protein-1β 
(MIP-1β) during infection of alveolar macrophages (102). 
In cultured cells, PRRSV modulates pro-inflammatory cytokine levels in a cell 
type dependent fashion. PRRSV suppresses IL-1α, IL-1β, TNF-α and IL-12p40 following 
infection of PAMs (102, 173). Similarly, PRRSV does not induce IL-6, IL-8, IL-12, and 
TNF-α from plasmacytoid dendritic cells (20). However, in bone marrow-derived 
immature dendritic cells, PRRSV up regulates IL-1, IL-6, IL-8, but not IL-12 and TNF-α 
(22). In immature monocyte-derived dendritic cells, PRRSV does not induce IL-12, but 
induce weak TNF-α at 24 h and 48 h post-infection (190). However, a particular strain of 
PRRSV up regulates IL-12 and TNF-α in monocyte-derived dendritic cells (132). 
PRRSV Nsp2 protein down modulates IL-1β and TNF-α (27).  
7.2. Anti-viral cytokines that inhibit PRRSV replication  
Treatment of pigs with recombinant porcine IL-12 reduced PRRSV viral 
replication in PAMs by inducing IFN-γ (21). Similarly, another IFN-γ-inducing cytokine, 
IL-18 inhibits PRRSV replication in permissive cells (25). IFN-γ has anti-viral effects on 
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PRRSV replication by a dsRNA-inducible protein kinase (PKR) dependent fashion (145). 
This effect is dose-dependent and dependent on the length of exposure prior to infection 
(8). TNF-α and IFN-α also have anti-viral effects on PRRSV replication (100, 102). 
Treatment of PAMs with TNF-α before or during infection reduces PRRSV titers in the 
supernatant (102). Interestingly, most IFN-α subtypes contribute to anti-viral effects on 
PRRSV replication (150). Viral isolates have different sensitivity to anti-viral effects of 
IFN-α and have different abilities to induce IFN-α (100). Recently, recombinant porcine 
IL-29 was shown to have an anti-viral effect on PRRSV replication (189). 
7.3. Modulation of anti-inflammatory cytokines during PRRSV infection 
Certain PRRSV strains stimulate anti-inflammatory cytokines such as IL-10 and 
TGF-β. Piglets infected in utero have increased levels of IL-10 mRNA after four weeks 
of age (72). Similarly, several experiments with different PRRSV strains showed up 
regulated IL-10 expression that reached maximum levels at 7-9 days post-infection (45, 
92). Leukocytes and monocytes may up regulate IL-10 levels in PRRSV-infected 
broncho-alveolar lavage cells (BALC) and PBMCs respectively (23, 170). In vitro studies 
in dendritic cells revealed PRRSV induces IL-10 in mature monocyte-derived and bone 
marrow-derived dendritic cells but not in immature monocyte-derived dendritic cells (22, 
55, 190). Independent studies also demonstrated that IL-10 responses during PRRSV 
infection are strain-specific (55, 165, 171). The levels of IL-10 during PRRSV 
anamnestic responses are inversely correlated with the number of IFN-γ secreting T cells 
during experimental infection and vaccination with different European genotype strains 
(44, 45). However, in Foxp3+CD25+T regulatory cells detected after PRRSV infection, 
transforming growth factor-β (TGF-β) but not IL-10 is induced (155).  
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7.4. Modulation of T cell cytokines by PRRSV 
In response to PRRS virus stimulation, T cells induce IL-2 and IFN-γ but not IL-4 
and IL-10 during T cell proliferation (123). PRRSV-infected monocytes suppress IFN-γ 
and TNF-α secretion from PMA/ionomycin activated T cells, which is dependent on IL-
10 induction from infected monocytes (23) .  
8. TNF-α and its modulation by viruses 
8.1. Biological functions of TNF-α 
 TNF-α is an immediate-early cytokine secreted mainly by macrophages, dendritic 
cells, and T cells. TNF-α binds two cellular receptors, TNFR1 (p55) and TNFR2 (p75), 
both of which are essential for mediating anti-viral innate immunity in target cells (146). 
TNF-α induces apoptosis in cells infected with viruses and intracellular bacteria. TNF-α 
also establishes inflammation by inducing other pro-inflammatory cytokines such as IL-1, 
IL-6 from monocytes/macrophages, and pro-inflammatory chemokines such as IL-8 from 
fibroblasts at the site of infection (177). It also up regulates the adhesion molecules on the 
surface of vascular endothelial cells to promote inflammatory cellular infiltration (177). 
In T cells, TNF-α signaling through TNFR2 acts as a co-stimulatory signal that is 
essential for T-cell activation and proliferation when antigen presentation is weak (80). 
However, it also induces apoptosis in mature CD8+ T cells in TNFR2-dependent manner 
(207). 
8.2. Mechanism and Regulation of TNF-α induction 
 TNF-α production is tightly regulated virtually at nearly each step of its 
biosynthesis. TNF-α can be induced by activation of toll-like receptors such as TLR4 and 
TLR7 in response to microbial products. TLR activation leads to several intracellular 
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pathways that ultimately up regulate production of membrane and soluble TNF-α. First, it 
activates several distinct signaling pathways that lead to assembly of transcription factors 
such as Sp1, NF-κB, CBP, Egr-1, Elk-1, ATF2-c-jun, AP-2 on TNF-α promoter to 
activate transcription (52, 179). Second, TLR activation also stabilizes the mature TNF-α 
mRNA through AU-rich element present in 3’untranslated region (15). The primary 
product of TNF-α translation is a membrane form that is cleaved to produce soluble form 
by TNF-α converting enzyme (TACE) (206). 
8.3. Modulation of TNF-α by viruses 
TNF-α has anti-viral effects towards DNA and RNA viruses (198).  For example, 
it controls replication of herpes simplex virus or murine cytomegalovirus in infected 
macrophages (66). TNF-α also restricts respiratory syncytial virus replication in alveolar 
macrophages (31). Several viruses encode proteins that inhibit TNF-α.  In addition to 
PRRSV, African swine fever virus (ASFV), and herpes simplex virus-1 (HSV-1) 
suppress TNF-α production during infection (64, 117). Poxviruses, adenoviruses, and 
hepatitis C virus employ different strategies to block TNF-α signaling pathway and 
prevent apoptosis of infected cells (85). In contrast, Human immunodeficiency virus 
(HIV) viral proteins activate TNF-α signaling in infected cells and bystander non-infected 
cells to sustain the viral infection or induce apoptosis respectively (67). 
9. IL-10 and its modulation by viruses (1) 
9.1. Biological functions of IL-10 
 IL-10 is an anti-inflammatory cytokine secreted by monocytes, macrophages, 
dendritic cells, T cells, B cells, and mast cells (118).  It has anti-inflammatory and 
immunosuppressive activities (139). IL-10 reduces pro-inflammatory cytokine responses 
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and inhibits antigen-specific T cell activation (118). IL-10 antagonizes production and 
function of several cytokines such as TNF-α, IL-1, GM-CSF, IFN-γ, IL-2, IL4 and IFN-γ 
(118). It also down regulates MHC proteins and co-stimulatory molecules on the surface 
of macrophages and dendritic cells (118). More importantly, IL-10 directly suppresses 
the activity of T helper 1 cells thereby inhibiting CMI responses (118).  
9.2. Modulation of IL-10 by viruses 
 Several intracellular pathogens that survive in macrophages, dendritic cells, or B 
cells exploit IL-10 induction pathways to dampen immune responses against them (139). 
Typically, persistent viral infections such as lymphocyte choriomeningitis virus (LCMV), 
HIV, Hepatitis C virus (HCV), Epstein Barr virus (EBV), Human cytomegalovirus 
(HCMV) are associated with high levels of IL-10 (16, 139, 157). HIV encodes several 
proteins to induce IL-10 from macrophages and T cells (139), which may contribute to 
immunosuppression during later stages of infection. LCMV induces IL-10 to suppress 
antigen-specific CD8+ T cells which favors viral persistence (16). HCV induces IL-10 to 
suppress Th1 responses in infected individuals (13). EBV and HCMV encode viral IL-10 
homologs to dampen adaptive immune responses (157). Similarly, some PRRSV strains 
induce IL-10 in infected pigs which antagonize IFN-γ specific T cell responses (44, 45).  
10. PRRSV vaccine development 
 Currently, live attenuated and inactivated virus vaccines are commercially used to 
control PRRSV in swine populations worldwide (83). Unfortunately, both types of 
vaccines are not effective in protecting pigs from PRRSV field infections (91). Live 
vaccines have additional problems such as reversion to virulence, and establishment of 
viral persistence in vaccinated animals (79, 128). Availability of several reverse genetics 
21 
systems for PRRSV (114, 126, 178) may facilitate the development of safe attenuated 
live virus vaccines by rational introduction of mutations at multiple positions in viral 
genome. To this end, chimeric viruses developed by swapping genes between virulent 
and attenuated viruses enlighten the role of several viral proteins in virulence/attenuation 
(89).  
Interestingly, PRRSV virulence is regulated by both non-structural and structural  
genes (89). Viral proteins such as Nsp3 to Nsp8, GP2 and GP5 contribute primarily to 
virulence, while Nsp1, Nsp2, Nsp10-Nsp12 may have additional roles in virulence (89). 
These studies collectively proved that non-structural proteins are important components 
in PRRSV virulence. Dissecting multiple virulence determinants in non-structural and 
structural proteins could lead to the development of attenuated live virus vaccines that 
cannot revert back to virulence.  
11. Objective  
 The ultimate objective of this dissertation is to generate PRRSV mutant viruses 
that up regulates TNF-α but fail to induce IL-10 in infected pigs. It is expected that such 
mutant viruses will be attenuated and activate optimal immune responses in swine. 
Consequently, we evaluated TNF-α/IL-10 responses against a bona fide virulent 
infectious clone-derived strain, vFL12 in vitro and/or in vivo. We confirmed the TNF-α 
suppressing phenotype but not IL-10 inducing phenotype with vFL12 strain. Using 
reporter assays and mutageneic studies, we characterized viral proteins important for 
TNF-α suppression and their underlying mechanisms. Furthermore, we attempted to 
generate PRRSV mutant viruses that are attenuated but up regulated TNF-α expression in 
infected cells. 
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ABSTRACT 
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to 
suppress tumor necrosis factor-alpha (TNF-α) in infected macrophages. The objective of 
this study was to identify the PRRSV-encoded proteins that are responsible for the 
inhibition of TNF-α expression and the mechanism(s) involved in this phenomenon. 
Using a swine TNF-α promoter-specific luciferase reporter system, only the non-
structural protein 1 (Nsp1) was found, out of a total of 11 PRRSV-encoded proteins 
screened, to strongly suppress the TNF-α promoter activity. Such inhibition takes place at 
the promoter’s proximal region. Both Nsp1α and Nsp1β, the two proteolytic fragments of 
Nsp1, were shown to be involved in TNF-α promoter suppression. Furthermore, using 
reporter plasmids specific for transcription factors (TFs) that bind to the proximal region 
of TNF-α promoter, Nsp1α and Nsp1β were found to inhibit the activity of the TFs that 
bind CRE-κB3 and Sp1 elements respectively. Subsequent analyses showed that Nsp1α 
moderately inhibits NF-κB activation and that Nsp1β completely abrogates the Sp1 trans-
activation through its B domain. These findings reveal one of the important mechanisms 
underlying the innate immune-evasion by PRRSV during infection and provide avenues 
to construct rationally designed attenuated PRRSVs for vaccine development. 
Keywords: PRRSV, Tumor necrosis factor-α, promoter suppression, NF-κB, Sp1, Innate 
immune evasion 
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INTRODUCTION 
Porcine reproductive and respiratory syndrome is an economically important 
disease causing losses to swine industry worldwide. The disease is characterized by late 
term reproductive failure in sows and respiratory distress in young growing pigs (192). 
The severity of the disease in young pigs is related to the age and the multi-factorial 
nature of the disease. The disease is caused by porcine reproductive and respiratory 
syndrome virus (PRRSV), an arterivirus that belongs to the order, Nidovirales. The virus 
is a single-stranded, positive-sense RNA virus having a genome of approximately 15 kb 
in size (115). PRRSV predominantly replicates in differentiated cells of myeloid lineage 
such as macrophages and dendritic cells (48, 190, 192). Since macrophages and dendritic 
cells are major producers of innate defensive cytokines such as interferon-alpha (IFN-α) 
and tumor necrosis factor-alpha (TNF-α) during viral infections, it is plausible that 
PRRSV can actively suppress their induction in order to replicate in the host cells and 
fulfill the pathogenic goal of establishing persistency in the host (3, 10, 102). In addition, 
the defective induction of innate immune responses against PRRSV may contribute to the 
delayed and weak development of antigen-specific adaptive immune responses later 
during PRRSV infection (105, 110). PRRSV encodes 8 open reading frames that produce 
14 non-structural proteins (Nsps) and 7 structural proteins. Recent studies from our 
laboratory have shown that several proteins such as Nsp1, Nsp2, Nsp4, and Nsp11 are 
able to suppress IFN-β promoter activation (10). These proteins suppress the induction of 
Type I IFNs and their signaling by inhibiting transcription factors such as interferon 
regulatory factor-3, nuclear factor-κB, CREB-binding protein (CBP) and signal 
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transducers and activators of transcription-1 (STAT-1) (10, 26, 82). However, the 
molecular mechanisms underlying the TNF-α suppression by PRRSV are unknown. 
TNF-α is an immediate-early cytokine, which is secreted in response to various 
viral infections by activated macrophages, dendritic cells and T cells (68, 108, 130). 
TNF-α has two biological functions: First, it induces apoptosis in virus-infected cells. 
This effect is synergistically augmented by the presence of IFN-γ (198). Second, TNF-α 
promotes inflammation by inducing the production of other pro-inflammatory cytokines 
at the vicinity of infection (177). TNF-α directly inhibits replication of both DNA and 
RNA viruses in vitro (31, 66, 198). Viruses such as African swine fever virus (ASFV) 
and herpes simplex virus-1 (HSV-1) directly inhibit induction of TNF-α during infection 
(64, 117).  Several studies have shown that PRRSV is also able to suppress TNF-α 
production both in vitro and in vivo. (102, 173, 184, 185).  
The objective of the present study was to identify the PRRSV proteins that inhibit 
TNF-α expression, especially at the promoter level, and determine the underlying 
mechanism(s). Among 11 PRRSV-encoded proteins screened, only Nsp1 was able to 
strongly suppress the TNF-α promoter. Moreover, both Nsp1α and Nsp1β, products of 
Nsp1 derived by auto-cleavage process, were involved in the TNF-α promoter 
suppression.  Further detailed analyses showed that Nsp1α and Nsp1β inhibit TNF-α 
promoter by inhibiting NF-κB activation and Sp1 trans-activation, respectively. These 
findings provide a mechanistic understanding of how PRRSV utilizes two of its non-
structural proteins to suppress the TNF-α promoter activation. This study also gives 
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insights into how PRRSV evades the immune response by inhibiting innate immune 
defenses during infection. 
MATERIALS AND METHODS 
Cell lines and viruses 
RAW264.7, a murine macrophage cell line (obtained from ATCC) was 
maintained in RPMI-1640 with 25mM HEPES (Mediatech) supplemented with 10% fetal 
bovine serum (FBS). MARC-145 cells (obtained from Dr. Will Laegrid, USMARC, and 
USDA/ARS) were maintained in DMEM supplemented with 10% FBS. PRRSV vFL12 
virus, an infectious clone-derived highly virulent North American strain (88, 178), was 
propagated and titrated in MARC-145 cells. 
Preparation and phenotypic characterization of monocyte-derived macrophages 
 The procedure for the preparation of monocyte-derived macrophages was 
followed as previously described with some modifications (106). Briefly, peripheral 
blood mononuclear cells (PBMCs) were isolated from heparinized blood by density-
gradient centrifugation using lymphocyte separation medium (Mediatech). Monocytes 
were enriched from PBMCs by glass adherence overnight in DMEM supplemented with 
10% FBS. Non-adherent lymphocyte populations were removed by rigorous washing 
with PBS. Subsequently, the enriched adherent monocytes were incubated with RPMI-
1640 (Gibco) supplemented with 10% FBS, 25mM HEPES, 1mM sodium pyruvate, 1X 
non-essential aminoacids, 50µg/mL gentamicin (Sigma) and 5ng/mL murine 
macrophage-colony stimulating factor (M-CSF) for 7 days. After 7 days, differentiated 
macrophages were harvested using Hank’s salt solution (HSS)-based cell dissociation 
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buffer (Invitrogen). The cells were phenotypically characterized by flow cytometry using 
the following mouse primary antibodies namely anti-SWC3 mAb, anti-MHCII mAb 
(VMRD), anti-CD163 mAb (Abserotec) and a goat anti-mouse IgG secondary antibody 
conjugated with Alexafluor 488 (Invitrogen). Staining with secondary antibody only was 
used as negative control.  
Quantitative PCR and ELISA for swine TNF-α 
Monocyte-derived macrophages were infected with PRRSV, vFL12 strain, at 
MOI 10 or stimulated with lipopolysaccharide (LPS) (1µg/mL) for indicated time points. 
Total RNA was isolated from cells using Trizol-LS reagent (Invitrogen). Total RNA (1-
2µg) was reverse-transcribed using MMLV-RT (invitrogen) and oligo-dT as primer. The 
complementary DNAs (cDNAs) synthesized were used as templates to quantify the 
mRNA copy numbers for TNF-α and β-actin by quantitative PCR (qPCR) using 
sequence-specific primers and Taqman probes (90):  TNF-α: forward primer 
TCCAGTGGCAGAGTGGGTATG, reverse primer CCATCTGTCGGCACCACC, and 
probe AATGCCCTCCTGGCCAACGGC. β-actin: forward primer CTCCTTCCTGGG
CATGGA, reverse primer CCACGTCGCACTTCATGATC, and probe TGCGG
CATCCACGAGACCACCT.  All primers and probes were custom-synthesized from 
Sigma-Genosys. The optimized concentrations were TNF-α: primer (300nM each); probe 
(900 nM); β-actin: primer (250nM each); probe (900nM). qPCR was performed using 
Fast start PCR master mix (Roche Applied sciences), the reactions were run in 
Smartcycler (Cepheid) and the thermal profile included:  95
○
C for 10 min (hot start) 
followed by 95
○
C for 15 sec (denaturation), 72
○
C for 60 sec (extension) for a total of 40 
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cycles. The mRNA copy numbers were calculated based on a standard curve prepared 
with known amount of PCR products. The TNF-α mRNA copy numbers were normalized 
with β-actin mRNA copy numbers which served as internal control. The relative TNF-α 
mRNA copy numbers (%) were calculated as previously described (163). TNF-α protein 
levels in supernatant were measured by using a commercial swine TNF-α specific ELISA 
as per manufacturer’s instructions (Pierce). 
 Plasmids construction 
 The plasmids, pGL3-Basic and pGL4.32NFkBRE-luc were purchased from 
Promega.  pswTNF-α-luc plasmid was constructed by cloning swine TNF-α promoter 
sequences (-1348 to +58, position +1 refers to transcription start site of TNF-α gene, 
NCBI accession No: NC_010449) into pGL3 basic vector (Promega). pswTNFa-194 luc 
was constructed by cloning  -194 to +58 region of TNF-α promoter into pGL3-basic 
vector. All plasmids expressing non-structural proteins of PRRSV were described 
previously (10). Plasmids expressing exact sequences of Nsp1α and Nsp1β were 
constructed by cloning nucleotide (nt) 192-731 and nt 732-1340 sequences of vFL12 
(Genbank accession no: AY545985) into CMV-based expression vector, pIHA-FLAG, 
which was described previously (10). The expression of these constructs was confirmed 
by western blot analysis using rabbit poly-clonal antibody custom-developed against 
PRRSV-vFL12-Nsp1 (Open Biosystems). TF-specific reporter plasmids were constructed 
by cloning sequences of 3X Sp1/Egr1RE or 3X CRE-kB3 RE or 5X Sp1RE fragments 
(indicated in Fig 3A,whose sequences were derived from swine TNF-α promoter) into  
pGL4.32 vector (Promega) by replacing 5X NF-κB RE fragment between Nhe I and Bgl 
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II cloning sites. GAL4-Sp1TAD expressing plasmid was constructed by cloning the 
trans-activation region (1-615 amino acids) of Sp1 (GenBank Accession No: 
NM_013672.2) fused in frame with DNA binding domain (1-147 amino acids) of Gal4 
(GenBank Accession No: NC_001148) in a mammalian expression vector, pCDNA3.1+ 
(Invitrogen). Gal4-Sp1-N, Gal4-Sp1B and Gal4-Sp1Bc were constructed by cloning 90-
615, 263-542, and 421-542 amino acid sequences of Sp1 respectively in frame with Gal4 
DNA binding domain in pCDNA3.1+ vector. Sequences of all primers used for PCR 
amplication were indicated in Table 1. The 5X Gal4RE-luc was constructed by cloning 
five tandem repeats of Gal4 responsive element, using the following natural Gal10 
promoter sequence ACGGAGGAGAGTCTTCCGTCGGAGGGCTGTCGCCCGCTCG
GCGGCTTCTAATCCGT (GenBank accession no: NC_001134, underlined sequences 
correspond to Gal4 binding elements) into pGL4.32 vector by replacing NFκB-RE 
element as described above.  
RAW cell transfection and luciferase reporter assays 
RAW 264.7 cells were transfected with all plasmids using DEAE-dextran 
chemical transfection by a procedure that has been slightly modified from a previous 
report (51).  Briefly, 2.0x10
5
 cells /mL were plated in a 12-well plate one day before 
transfection. Just before transfection, cells were washed once with serum-free RPMI 
medium. Then, cells were incubated for 2 h with 1 mL of transfection cocktail prepared 
with serum-free RPMI medium that contains 50mM Tris-Cl, pH 7.4, 1.6mg of DEAE-
dextran (Sigma) and required amount of plasmid DNAs.  After 2 h of incubation at 37
◦
C, 
cells were washed twice with serum-free RPMI medium followed by treatment with 10% 
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DMSO (prepared in PBS) for 1 min. Then, cells were washed again twice with serum-
free RPMI medium before adding the growth medium. For western blotting analysis, 
final growth medium was supplemented with 0.5µM 5-azacytidine to increase the 
transfection efficiency as described previously (51). For luciferase reporter assays, cells 
were transfected with PRRSV protein-expressing plasmids along with relevant firefly 
reporter plasmid (200ng), pRL-TK (Promega) renilla vector (10ng) and further incubated 
for 24 h at 37
◦
C to facilitate protein expression. After 24 h of incubation, transfected 
RAW cells were stimulated with LPS (Sigma) (1µg/mL) for 6 h to stimulate the promoter. 
Cells were then lysed and luciferase activities were measured in GloMax 20/20 
luminometer (Promega) using dual luciferase assay kit as per manufacturer’s instructions 
(Promega). Firefly luciferase activities in stimulated cells were expressed as luciferase 
units relative to unstimulated cells after normalizing the transfection efficiency with 
renilla luciferase values. 
RESULTS 
PRRSV reduced TNF-α production in infected swine macrophages 
 Previous studies have shown that PRRSV induces a weak TNF-α response during 
in vitro and in vivo infections (102, 185). In order to reconfirm the defective TNF-α 
response during PRRSV infection in our own experimental system, macrophages were 
derived in vitro from peripheral blood mononuclear cells (PBMCs). The phenotype of 
these macrophages was characterized by flow cytometry and it was found to be 
SWC3
+
MHCII
+
CD163
+
. These cells were found to be permissive for PRRSV to a level 
comparable to that exhibited by pulmonary alveolar macrophages, the natural host cells 
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for PRRSV in vivo (data not shown). These PBMC-derived macrophages were infected 
with a highly virulent PRRSV strain derived from an infectious clone, FL12 (88, 178) at 
a multiplicity of infection of 10. LPS-stimulated cells and mock-infected cells were used 
as positive and background controls for TNF-α response, respectively. When TNF-α 
mRNA levels were measured by quantitative PCR, there were no signals during 2 and 6 h 
post PRRSV infection (PI), when compared to LPS-stimulated cells (Fig 1A). However, 
significant levels of TNF-α mRNA were observed at 12 and 24 h PI. Even though there 
was a delayed TNF-α transcriptional response observed during PRRSV infection, there 
were no detectable levels of secreted TNF-α protein in the supernatant of infected 
macrophages as determined by ELISA (Fig 1B). The kinetics of PRRSV infection in the 
infected macrophages was measured by titrating virus contained in the supernatant of 
infected cells, which showed peak viral titers at 12 h PI (Fig 1C). Hence, PRRSV induces 
a delayed TNF-α transcriptional response, which coincides with peak viral replication but 
fails to elicit TNF-α protein secretion during in vitro infection in PBMC-derived 
macrophages.  
PRRSV Nsp1α and Nsp1β suppressed the activation of the proximal region of swine 
TNF-α promoter  
 African Swine Fever Virus A238L protein inhibits TNF-α production by 
modulating the activity of transcription factors at the promoter level (64). In the current 
study with PRRSV, we examined which PRRSV proteins are involved in the down-
regulation of TNF-α expression at the promoter level. To this end, a swine TNF-α 
promoter-based luciferase reporter plasmid was constructed and used to screen various 
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PRRSV non-structural proteins and the N protein for suppression of the reporter activity 
in transfected RAW 264.7 cells. We used LPS, a known inducer of TNF-α, to activate 
swine TNF-α promoter. Upon LPS stimulation, of all the PRRSV proteins tested, only 
Nsp 1 suppressed swine TNF-α promoter activation (Fig 2A). Previous reports suggested 
that the proximal region of TNF-α promoter (-192) was sufficient for activation of TNF-α 
promoter (65, 203). Hence, the effect of Nsp1 on the proximal region (-194) of TNF-α 
promoter was next examined.  As shown in Fig 2B, Nsp1 was able to suppress the 
proximal region (-194) of swine TNF-α promoter in transfected cells suggesting that 
Nsp1 suppression lies in the proximal region of the promoter.  
PRRSV Nsp1 is auto-cleaved into two separate proteins, Nsp1α and Nsp1β in 
infected cells (26, 42). Recently, the exact cleavage site between Nsp1α and Nsp1β has 
been determined (26, 166). To determine their role, coding regions of Nsp1α and Nsp1β 
were cloned separately in frame with an N-terminal flag tag under CMV promoter. As 
shown in Fig 2C, both Nsp1α and Nsp1β equally suppressed the TNF-α promoter but not 
to the levels of the full-length Nsp1 protein. In summary, both subunits of Nsp1 were 
collaboratively involved in the TNF-α promoter suppression.  
Effect of PRRSV Nsp1α and Nsp1β on different transcription factors that bind to 
TNF-α promoter 
Different transcription factors are known to bind TNF-α promoter especially at -
192 proximal region of the promoter and form a specific transcriptional complex upon 
activation by various stimuli (52, 179). The pair-wise sequence alignment comparison of 
human and swine TNF-α proximal promoter sequences (Fig 3A) shows that the 
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transcription factor binding sites (except Sp1/Egr1 binding site) seem to be well 
conserved between humans and pigs.  With the aim of finding the transcription factors 
affected by Nsp1α and Nsp1β, luciferase reporter plasmids specific for different 
functional transcription factors were constructed by utilizing specific sequences derived 
from swine TNF-α promoter (Fig 3B).  In addition, Gal4, a yeast transcription factor-
specific reporter plasmid was also constructed as a negative control. As shown in Fig 3C, 
Nsp1α significantly suppressed the activity of transcription factors at CRE-κB3. It was 
also found to weakly suppress the activity of transcription factors that bind to the 
Egr1/Sp1 element. However, Nsp1β but not Nsp1α suppressed the activation of Sp1 at 
the proximal site of the TNF-α promoter including the distal Egr1/Sp1 element (Fig 3B). 
In conclusion, Nsp1α partially inhibited the transcription factors that bind to CRE-κB3 
while Nsp1β strongly inhibited the activity of Sp1 at both sites in the TNF-α promoter.  
PRRSV Nsp1α partially inhibited NF-κB activation 
Nsp1α was able to suppress the transcription factors that bind CRE-κB3 element 
of TNF-α promoter (Fig 3C). ATF2/c-jun and p65/p50 complexes are known to directly 
interact with CRE and κB3 sites respectively (179). Many viruses such as human 
immunodeficiency virus and poxviruses are known to encode proteins that modulate 
nuclear factor-κB (NF-κB) activation during infection (12, 125). Hence, the effect of 
Nsp1α on NF-κB activation was next examined. To this end, using a reporter plasmid 
specific for NF-κB activation, Nsp1α was found to partially suppress the NF-κB 
activation in transfected cells upon LPS stimulation (Fig 4). Hence, the Nsp1α mediated 
an inhibitory effect on NF-κB activation to suppress the activation of TNF-α promoter. 
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PRRSV Nsp1β strongly inhibited the trans-activation of Sp1 especially through its B 
domain 
Nsp1β was found to inhibit the reporter activity specific to endogenous Sp1 upon 
LPS stimulation (Fig 3C). Consistently, Sp1 is recruited to TNF-α promoter in an 
inducible manner during virus infections in different cell types (52). Since Sp1 is a 
transactivator at many inducible promoter activations (195), we examined whether Nsp1β 
affects the trans-activation potential of Sp1.  The N-terminal sequences (1-615 amino 
acids position) of Sp1 were found to mainly contribute to the trans-activation potential of 
Sp1 (195). It was fused in frame with DNA binding domain of Gal4, a yeast transcription 
factor to construct Gal4-Sp1 fusion protein (Fig 5A).  The Gal4-Sp1 fusion protein can 
bind Gal4 responsive element containing promoter to stimulate the reporter activity in 
transfected cells upon LPS stimulation. This reporter activity is then directly proportional 
to the trans-activation potential of Sp1 N-terminal region fused to Gal4 DNA binding 
domain. As shown in Fig 5B, Nsp1β was able to completely suppress the trans-activation 
of Sp1 upon LPS stimulation.  
The trans-activation potential of Sp1 is mainly carried out by A and B domains of 
Sp1, each of which contains a glutamine-rich domain (195). In addition, Sp1 has a 
negative inhibitory domain at its n-terminus which can repress the trans-activation 
mediated through other domains, such as A and B domains, by recruiting transcriptional 
repressors and co-repressors to Sp1 (99, 121). During activation, this negative inhibitory 
domain is removed by ubiquitin-dependent proteasomal activity (160). Complete removal 
of this negative regulatory domain from Sp1 trans-activation region did increase the 
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trans-activation ability of Sp1 but did not have any effect on the ability of Nsp1β to 
suppress the activity of Sp1 (Fig 5C). Hence, N-terminal negative inhibitory domain of 
Sp1 was not necessary for Nsp1β-mediated inhibition of Sp1 trans-activation. LPS was 
found to activate trans-activation of Sp1 mainly through its B domain rather than A 
domain (14). Gal4 fusion protein with only B domain of Sp1 showed trans-activation 
ability comparable to that of the whole trans-activation region without N domain (Fig 5C 
and Fig 5D). Moreover, it was known that glutamine-rich C-terminal region of Sp1 B 
domain (Sp1Bc) was found to be sufficient for activation of Sp1-dependent promoter (60). 
Hence, we investigated whether Nsp1β was able to suppress the B domain especially 
through its glutamine-rich C-terminal region. As shown in Fig 5D, Nsp1β strongly 
suppressed the trans-activation of Sp1 B domain including its glutamine rich C-terminal 
region. Overall, Nsp1β reduced the TNF-α promoter activity by suppressing the trans-
activation of Sp1 probably by modulating the interactions of glutamine-rich region of Sp1 
B domain. 
DISCUSSION 
Porcine reproductive and respiratory syndrome virus replicates in macrophages 
and dendritic cells and suppresses cytokines such as Type I interferons and TNF-α (10, 
26, 82, 102). In this paper, we identified the PRRS viral protein-Nsp1 that mediated such 
suppression at the level of the promoter of TNF-α. Moreover, we found that both 
constitutive subunits of Nsp1 (Nsp1α and Nsp1β) suppressed the TNF-α promoter by 
modulating activities of transcription factors NF-κB and Sp1, respectively. Our data also 
suggested that by inhibiting transcription factors activated by two important pathways, 
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NF-κB pathway and MAPK pathway, PRRSV effectively reduced the TNF-α promoter 
activity to suppress TNF-α-mediated apoptosis of infected cells.  
In our experiments, PRRSV induced negligible levels of TNF-α during in vitro 
infection of PBMC-derived macrophages. Particularly, TNF-α mRNAs were not induced 
at early time points after PRRSV infection, which would suggest that, at the MOI used, 
the genomic RNAs of input virus may not activate TNF-α gene. However, there was an 
up regulation of TNF-α mRNA levels observed at later time points of PRRSV infection. 
Moreover, there may be an involvement of a post-transcriptional mechanism used by 
PRRSV to suppress TNF-α production either at translation or at secretion levels. Even in 
the presence of TNF-α mRNAs at later phases of infection, the secreted levels of TNF-α 
were not detected. Our results were consistent with previous publications reporting that, 
apart from inducing anti-apoptotic transcripts, PRRSV does not up regulate TNF-α 
production during in vitro as well as in vivo infection (58, 173, 184, 185). Lopez-Fuertes 
et al. reported that PRRSV elicits a defective TNF-α transcriptional response during early 
hours of infection with no protein secreted at any time points after infection (102).  
In order to find the proteins that may have inhibitory effect on TNF-α promoter, 
several non-structural proteins and N protein of PRRSV were screened using a swine 
TNF-α promoter based luciferase reporter assay. LPS was used as a stimulant for TNF-α 
transcription in the luciferase assay to mimic TLR-mediated induction of TNF-α by virus 
(172). Only Nsp1 was found to be actively suppressing the swine TNF-α promoter. 
Hence, in addition to anti-IFN activities (10), Nsp1 also has an anti-TNF activity. 
Moreover, regarding Nsp1-mediated suppression, there was no difference observed 
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between a full-length TNF-α promoter and a region of TNF-α promoter involving 194 
nucleotides proximal to transcriptional start site. This proximal region of TNF-α 
promoter had been previously demonstrated to be sufficient for optimal stimulation of 
TNF-α promoter (131, 203). In addition to reducing type I IFN activities, both of the 
auto-cleaved subunits of Nsp1, Nsp1α and Nsp1β, were involved in the suppression of 
the TNF-α production. Full-length Nsp1 suppressed TNF-α promoter stronger than 
Nsp1α or Nsp1β do. Hence, it is conceivable that a synergistic functional interaction may 
exist between two Nsp1 subunits. It may also be plausible that the two subunits of Nsp1 
are synthesized at the early time points following PRRSV infection as they may have 
been selected evolutionarily to inhibit innate cytokines such as TNF-α and type I 
interferons. Hence, in addition to its role in replication, transcription and virion 
biogenesis (10, 26, 82, 124, 175), the multi-functional protein Nsp1 has anti-innate 
immunity roles that could facilitate viral replication in macrophages. This negative effect 
on innate immunity may play a key role in dampening subsequent adaptive immune 
responses during PRRSV infection.  
Both Nsp1α and Nsp1β suppressed the functional activities of different regions of 
the TNF-α promoter such as CRE-κB3 and Sp1 elements located in the proximal region of 
the promoter respectively (Fig 6). Hence, both these proteins may target some 
transcription factors that bind to these elements, which are strictly essential for TNF-α 
transcription regardless of the type of stimuli or cell type (52, 179). In that regard, Nsp1α 
was found to partially inhibit the activity of NF-κB in reporter assay which employs 
tandem NF-κB binding sites. Therefore, it is speculated that the Nsp1α-mediated 
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inhibition of NF-κB at κB3 may prevent the assembly of ATF2-c-jun-NF-κB complex at 
CRE-κB3 site and further recruitment of CBP or p300 to TNF-α promoter (59, 76). A 
previous study also shows that mutation in either CRE or κB3 element completely 
abrogates the functionality of CRE-κB3 site in the context of TNF-α promoter (203).  
In contrast to Nsp1α, Nsp1β suppressed a different transcription factor (Sp1) both 
at proximal and distal Sp1 binding sites. Nsp1β inhibited the trans-activation of Sp1, 
mediated through glutamine-rich region of its B domain that was demonstrated to be 
primarily involved in the LPS-mediated Sp1 trans-activation (14). Consequently, Nsp1β 
may prevent interactions of glutamine-rich Sp1 B domain with RNA polymerase initiator 
complex (TFIID) at the TNF-α promoter. The glutamine rich C-terminal region of Sp1 B 
domain (Sp1Bc) interacts with basal transcriptional machinery through direct interactions 
with transcription initiation factor TFIID subunit 4 (Taf4) and TATA binding protein 
(TBP) (50, 60). In addition to the suppression of Sp1 at proximal binding site, Nsp1β also 
strongly suppresses the transcription factors that bind to distal Egr1/Sp1 element. This 
may be explained by the fact that Egr1 and Sp1, both of which bind to this element, 
would be reciprocally regulating the activity of each other (147). Consequently, by 
inhibiting Sp1, Nsp1β would also control the activity of Egr-1 at this element.  
Furthermore, based on our studies, Nsp1β of PRRSV would be one of the rare 
examples of viral proteins of RNA viruses capable of modulating the inducible activity of 
Sp1 and inhibiting a Sp1-dependent gene, TNF-α. Only one other viral protein, HIV tat 
was shown to bind and modulate the activities of Sp1 (70). Interestingly, Sp1 is also 
involved in the expression of several immuno-modulatory genes such as MHC Class I 
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Chain-Related Protein A (MICA), interleukin-12 p35 subunit, etc. (4, 63). Therefore, the 
possible role of Nsp1β in the regulation of other Sp1-dependent genes during PRRSV 
infection would be of further interest.  
The logical extension of this research is to fine map Nsp1 sequences that are 
involved in TNF-α suppression. Using a reverse genetics approach, mutant viruses that 
relieve TNF-α suppression could be generated by mutating the sequences that normally 
suppress TNF-α in the context of PRRSV-FL12 full-length infectious clone. Such 
enhanced TNF-α production could be anticipated to limit PRRS viral replication in 
susceptible cells in vivo thereby reducing viremia and pathogenicity. In addition, the 
virus-induced TNF-α is expected to improve anti-viral adaptive immune responses 
especially by inducing other immuno-regulatory cytokines such as IL-8, IL-6, IL-1, thus 
potentially making such mutant PRRSV interesting as a putative live-attenuated virus 
vaccine candidate.  
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Table 1. Primers used for PCR amplification. 
Primer  Sequence (5′ to 3′)a 
pTNF-α-F ATATATCCTAGGGCTCTTTTCTCTGAAATGCTGTCTGC 
pTNF-α-R ATATATAAGCTTGGGTCCTGGAGATGGCTTGTCT 
pTNF-α-194-F ATATATCCTAGGCTTCCAAACCGCCGCCCCCGCTAT 
Nsp1-F ATATATCTCGAGATGTCTGGGATACTTGATCGG 
Nsp1-R ATATATGCGGCCGCTTTACCGTACCATTTGTGACTGC 
Nsp1α-R ATATATGCGGCCGCTTACATAGCACACTCAAAAGGGCA 
Nsp1β-F ATATATCTCGAGGCTGACGTCTATGATATTGGTCATG 
Gal4DBD-F ATATATGCTAGCCACCATGAAGCTACTGTCTTCTATCGAACAAG 
Gal4DBD-R ATATATGGATCCCGATACAGTCAACTGTCTTTGAC 
Sp1TAD-F ATATATGAATTCTATGAGCGACCAAGATCACTCCA 
Sp1TAD-R ATATATGCGGCCGCTTATGAGGCTCTTCCCTCACTGTCTT 
Sp1-N-F ATATATGAATTCTGGGGGCACAGGTGAACTTGAC 
Sp1B-F ATATATGAATTCTATCACCTTGCTACCTGTCAACAGC 
Sp1Bc-F ATATATGAATTCTTCCGGACAGACCTTCACAACTC 
Sp1B-R ATATATGCGGCCGCTTACTGGATCCCTGAAGTACCCAATGC 
 
a 
Primer sequences for TNF-α, Nsp1, Sp1, Gal4 were designed utilizing the sequences 
with NCBI accession numbers, NC_010449, AY545985, NM_013672.2 and NC_001148 
respectively. 
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Figure 1. PRRSV down modulates TNF-α response during in vitro infection in 
PBMC-derived macrophages. (A) Quantitative PCR analysis. PBMC-derived 
macrophages were either mock-infected or infected with PRRSV (vFL12 strain) at a 
multiplicity of infection of 10. LPS-stimulated cells were used as positive control. Cells 
were collected at indicated time points after infection. RNAs were isolated, cDNAs were 
prepared and subjected to quantitative PCR. The TNF-α mRNA copy numbers were 
normalized to β-actin mRNAs. Bars represent TNF-α mRNA copy numbers relative to 
that of mock control (mean ± standard error, n=3).  (B) Measurement of TNF-α protein 
by ELISA. Supernatants were collected from the above cultures and the TNF-α protein 
levels were measured by swine TNF-α-specific ELISA. Each bar represents mean ± 
standard error value (pg/mL) (n=3). (C) Measurement of viral titers in the supernatants 
obtained from above macrophage cultures infected with vFL12. Viral titers were 
measured in MARC-145 cells and expressed as tissue culture infectious dose50/mL.  
Mean ± standard error values are shown. 
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Figure 2. PRRSV Nsp1α and Nsp1β down-modulate the activity of TNF-α promoter 
at the proximal region. (A) Identification of PRRSV proteins that inhibit TNF-α 
promoter activity. RAW264.7 cells were transfected with pswTNF-luc plasmid (0.2 µg) 
along with plasmids expressing different PRRSV proteins (1µg) and a renilla luciferase 
vector (10ng). Transfected cells were incubated for 24 h and stimulated with LPS 
(1µg/mL) for 6 h. Firefly luciferase activities in cell lysates were measured and 
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normalized with the renilla luciferase activities. (B) Effect of Nsp1 on proximal region of 
TNF-α promoter. RAW 264.7 cells were transfected with a luciferase construct under the 
control of proximal region (-194) of TNF-α promoter (0.2µg) along with Nsp1-
expressing plasmid (1µg) and a renilla luciferase vector (10ng). Cells were stimulated 
and luciferase activities were measured as described above. (C) Role of Nsp1α and 
Nsp1β in mediating TNF-α promoter suppression. TNF-α promoter-luciferase assays 
were carried out as described above using plasmids that express Nsp1α and Nsp1β 
separately. Each bar represents the mean of luciferase units relative to unstimulated cells 
± standard error (n=3).  P-values<0.05 were considered significant, CV means control 
vector. 
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       Sp1   Egr1 
     .......T.C..........G.......A.....CG....................A...       Human 
-194 TTCCAAACCGCCGCCCCCGCTATGGAGATGAAACTAAGACAGAAGGTGCAGGGCCCGCTA    Swine 
 
        CRE       κB3   
     ...........................................................T       Human 
-137 CCGCTTCCTCCAGATGAGCTCATGGGTTTCTCCACCAAGGAAGTTTTCCGCTGGTTGAAA       Swine 
 
           Sp1                       TBP  
     ..T—T..T............C....G...CAG.GA.A......G....T....G......       Human 
 -77 GAGAGCCTCTCCCCGCCCTCTTCTCACCC--AGAGCGTATAAATGCAGCTGTTTGCACAC      Swine 
 
          ts 
     ..........G.C......TC..CA......G...A........T.A...G....G....       Human 
 -19 CCAGCCAGCAGAAGCTCCCAGAGTGAGGACACCAGGGGACCAGCCAGGAGAGAGACAAGC       Swine   
       ts 
 
     A.CTA.AGACC...                                  Human  
 +42 CATCTCCAGGACCC +58      Swine  
 
B      
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Figure 3. Transcription factors affected by Nsp1α and Nsp1β at the proximal region 
(-194) of TNF-α promoter. (A) Pair-wise sequence alignment of swine TNF-α promoter 
sequence (lower row) with that of human sequence (upper row). The nucleotides in the 
human sequence that are conserved with that in swine sequence are denoted by dots. 
Gaps in the sequences are denoted by dashes. Predicted functional elements that bind to 
transcription factors are in bold and underlined. The names of the cis-acting functional 
elements or binding transcription factors are indicated above the sequence. Number 
represents the position of nucleotide relative to transcription start site of human sequence. 
TBP means TATA binding protein. The transcription start sites of respective sequences 
were denoted as ts (+1 position). The ts of human was considered for all cases in this 
study.  
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(B) Illustration that shows the sequences and the tandem repeats of cis-acting TF-specific 
elements that were cloned upstream of a basal TATA promoter in a luciferase construct. 
The sequences of functional elements are depicted above the schematic diagrams of the 
constructs and are denoted in bold as well as underlined. (C) Effect of Nsp1 and its auto-
cleaved products on the activity of different transcription cis-acting functional elements 
of TNF-α promoter. RAW264.7 cells were transfected with each TF(s)-specific reporter 
construct (0.2µg) along with plasmids expressing Nsp1 or its auto-cleaved products (1µg) 
and renilla luciferase vector (10ng). After 24 h post-transfection, cells were stimulated 
with LPS and luciferase activities were measured. For non-specific luciferase activities, a 
Gal4-specific reporter construct was included. Mean ± standard error values (n=3) are 
shown. P<0.05 was considered significant. CV means Control Vector. 
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Figure 4. Nsp1α inhibits NF-κB activation. (A) RAW 264.7 cells were transfected with 
pGL4.32NF-κBRE-luc (0.2µg) along with plasmids expressing either Nsp1 or Nsp1α 
(1µg) and renilla luciferase vector (10ng). Cells were stimulated with LPS and luciferase 
activities were measured from cell lysates as described in the methods section. Mean ± 
standard error values (n=3) are shown. P<0.05 was considered significant. CV means 
Control Vector. 
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Figure 5. Nsp1β suppresses the trans-activation of Sp1. (A) Illustration that shows the 
sequences of Sp1 (black box) cloned in frame with Gal4 DNA binding domain (DBD, 1-
147 amino acids position, grey box). The letters above Sp1 TAD (black box) indicate the 
position of Sp1 domains in the trans-activation region. The bottom numbers indicate the 
position of amino acids in Sp1 sequence. (B) RAW264.7 cells were transfected with 
pGal4RE-luc (1µg), plasmids expressing Nsp1 or Nsp1β, pCDNA3.1 vector expressing 
Gal4-Sp1TAD fusion protein (1µg) and renilla luciferase vector (10ng). Cells were 
stimulated with LPS and luciferase activities were measured. (C and D) Effect of Nsp1β 
on the activity of N-terminal negative inhibitory domain (N domain) or internal trans-
activating B domain of Sp1. Trans-activation assays were carried out as described in the 
methods section. Briefly, pCDNA3.1 vector expressing Gal4 fusion proteins that lack 1-
90 amino acids of Sp1 (N domain) , that have either full-length B domain (263-542 
amino acids position) or C-terminal of B domain (421-542 amino acids position) of Sp1 
were used to trans-activate Gal4RE promoter of luciferase construct. Mean ± standard 
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error values (n=3) are shown. P<0.05 was considered significant. CV means Control 
Vector.      
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CHAPTER III 
 
 
 
 
Identification of amino acids in non-structural proteins 1α and 1β of 
porcine reproductive and respiratory syndrome virus that contribute to 
tumor necrosis factor-alpha down regulation 
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ABSTRACT 
 Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses tumor 
necrosis factor-alpha (TNF-α) production in vitro and in vivo. This suppressive activity 
occurs at both promoter and post-transcriptional levels. Specifically, PRRSV inhibits 
TNF-α promoter activation through non-structural proteins 1α and 1β (Nsp1α and Nsp1β). 
The objective of this study was focused on recovering mutant viruses that stimulate TNF-
α production in infected macrophages. First, Nsp1α and Nsp1β mutant constructs were 
created by site-directed mutagenesis. Nsp1α amino acid residues, Gly90, Asn91, Arg97, 
Arg100 and Arg124 were necessary for TNF-α promoter suppression in transient 
transfection assays. Several amino acid regions in all domains of Nsp1β were important 
for TNF-α promoter suppression. Subsequently, two mutant viruses, with mutations at 
Nsp1α Gly90 or Nsp1β 70-74 positions, were recovered by reverse genetics. The mutant 
viruses exhibited attenuated viral replication in vitro. Moreover, Nsp1α and Nsp1β 
mutant viruses up regulated TNF-α in infected macrophages at protein and mRNA levels. 
In addition, Nsp1α also reduced TNF-α protein expression post-transcriptionally in 
transfected cells. In infected pigs, the Nsp1β mutant virus was attenuated in growth when 
compared to infection with the wild type strain of PRRSV. These studies provide insights 
into how PRRSV evades the effector mechanisms of innate immunity during infection. 
Keywords:  Porcine reproductive and respiratory syndrome virus, Tumor necrosis factor-
alpha, Reverse genetics, Promoter regulation, Immune evasion 
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INTRODUCTION 
 Porcine reproductive and respiratory syndrome virus (PRRSV) causes late-term 
abortion in sows and respiratory disease in young pigs (28, 29, 143).  After infection, 
PRRSV replicates in lungs and secondary lymphoid tissues in the host and establishes a 
viremic period of about 3-4 weeks (49, 142, 143).  The viremic period is followed by a 
persistent period characterized by low levels of virus replication in secondary lymphoid 
tissues (3). The host immune response usually takes several months to clear virus from 
persistently infected swine (3).  
Previous studies demonstrated that the adaptive immune responses against 
PRRSV develop gradually, which prevents efficient clearing of the virus (3, 110). The 
ineffective adaptive immune responses against PRRSV are the result of various immune 
evasion strategies utilized by this virus to establish persistence in the host (5, 10, 34, 164, 
187).  One such strategy is inhibiting the key pro-inflammatory cytokine, tumor necrosis 
factor-α (TNF-α) in infected cells (102, 164). Since TNF-α can inhibit PRRSV 
replication in macrophages (102), PRRSV-mediated TNF-α suppression would enhance 
virus production in the infected host. 
Our laboratory previously showed that PRRSV suppresses TNF-α at the promoter 
and perhaps post-transcriptionally during infection (164). Interestingly, PRRSV only 
suppressed the TNF-α promoter at early times after infection (164). Even though TNF-α 
transcripts were abundant at later time points after infection, secreted TNF-α was not 
detected in the infected culture supernatant (164). These observations suggested that a 
post-transcriptional mechanism suppresses TNF-α during PRRSV infection. PRRSV non-
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structural proteins, Nsp1α and Nsp1β inhibited TNF-α promoter activity by affecting two 
different transcription factors, NF-κB and Sp1 that are important for activating the TNF-α 
promoter (164). 
Nsp1α and Nsp1β are non-structural proteins that participate in various aspects of 
the PRRSV life cycle such as transcription, virion biogenesis and innate immune evasion 
(10, 87, 175). Nsp1α contains 180 amino acid residues forming two domains, an N-
terminal zinc finger domain (ZF domain) and a C-terminal cysteine protease (PCPα) 
domain (166). Nsp1β contains 203 amino acid residues forming three domains, an N-
terminal nuclease domain, a linker domain and a C-terminal cysteine protease (PCPβ) 
domain (201). The PCPα and PCPβ domains auto-cleave Nsp1α and Nsp1β from ORF1a 
polyprotein, respectively (87). Upon cleavage and activation, both of these proteins 
homo-dimerize (166, 201). PCPα-mediated auto-cleavage of Nsp1α is essential for 
transcription of viral sub-genomic RNAs (87). Likewise, PRRSV Nsp1α ZF domain may 
also directly involve in viral transcription (53, 175). On the other hand, PCPβ-mediated 
auto-cleavage of Nsp1β is essential for PRRSV replication (87). In addition, the Nsp1β 
nuclease domain cleaves double-stranded DNA, and single-stranded RNA in vitro (201).  
However, the Nsp1α and Nsp1β sequences necessary for reducing TNF-α promoter 
activity are unknown.  
In this study, I demonstrated that five Nsp1α amino acid residues, Gly90, Asn91, 
Arg97, Arg100, and Arg124 are necessary for reducing TNF-α promoter activity. Several 
amino acid sequences in Nsp1β are also necessary for reducing TNF-α promoter activity. 
Nsp1α amino acid residue, Gly90 is required for the efficient reduction of TNF-α via 
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post-transcriptional mechanism. The mutant viruses with mutations at Nsp1α Gly90 
residue or Nsp1β 70-74 amino acid positions were recovered. These mutant viruses 
enhanced TNF-α mRNA and protein levels in infected macrophages when compared to 
the infection with wild type virus. In infected swine, the Nsp1β mutant virus is growth-
attenuated when compared to the wild type virus. 
MATERIALS & METHODS 
Cell lines, preparation of primary swine macrophages and viruses  
 RAW264.7 cells, a murine macrophage cell line (ATCC) was maintained in 
RPMI-1640 supplemented with 25mM HEPES, and 10% fetal bovine serum (FBS). 
MARC-145 cells, an African green monkey kidney epithelial cell line (obtained from Dr. 
Will Laegreid, USMARC, USDA/ARS) was maintained in Dulbecco’s modified eagle 
medium (DMEM)-low glucose supplemented with 0.7 g/L sodium bicarbonate, and 10% 
FBS. BHK-21, baby hamster kidney epithelial cell line was maintained in DMEM-high 
glucose supplemented with 3.4g/L sodium bicarbonate, and 10% FBS.   
Primary swine macrophages were prepared from peripheral blood mononuclear 
cells (PBMCs) as previously described (164). Briefly, PBMCs were isolated from blood 
by density-gradient centrifugation. Monocytes were prepared by glass adherence of 
PBMCs overnight. Adherent monocytes were differentiated into macrophages by 
incubating the cells in RPMI-1640 supplemented with 25mM HEPES, 10% FBS, 1mM 
sodium pyruvate, 1x non-essential amino acids, macrophage colony stimulating factor 
(5µg/mL) for seven days. Differentiated macrophages were harvested using cell 
dissociation buffer (0.06mM EDTA in PBS, pH 7.4).  
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PRRSV vFL12 strain and its mutant viruses were propagated and titrated in 
MARC-145 cells. Viral titers were calculated using the Reed and Muench method (140). 
Viral plaque assays were performed in MARC-145 cells. MARC-145 cells were 
incubated with vFL12 strain and its mutant viruses in ten-fold serial dilutions. After 1 h, 
cells were washed twice with PBS followed by overlay of growth agar medium. After 4 
days, cells were fixed with 2% glutaraldehyde and stained with 0.01% crystal violet. 
Luciferase Reporter Assays 
 Swine TNF-α promoter-luciferase reporter assay, Sp1 reporter assay, and Sp1 
trans-activation assays were carried out as previously described (164). Briefly, 
RAW264.7 cells were plated 24 h before transfection. Cells were incubated with plasmid-
transfection cocktail mix (1.6mg/mL DEAE-dextran (Sigma), 50mM Tris HCl, pH 7.4, 
RPMI-1640 medium) for 2 h. The reporter plasmids added in transfection cocktail mix 
were pswTNF-luc (0.2µg) for TNF-α promoter reporter assay, 5XSp1RE-luc (0.2µg) for 
Sp1 reporter assay, both pGal4RE-luc (0.2µg) and pCDNA3.1-Sp1TAD (1µg) for Sp1 
trans-activation assay and renilla luciferase expressing vector (10ng) for all assays. In 
addition to the reporter plasmids, wild type or mutant Nsp1α/Nsp1β-expressing plasmid 
(1µg) was added to each mix. After 2 h of incubation, cells were exposed to 10% DMSO 
(prepared in PBS, pH 7.4) for 1 min. Cells were then washed twice with RPMI medium 
and incubated in growth medium for 24 h.  
After 24 h, the reporter genes were stimulated with Lipopolysaccharide (LPS) 
(1µg/mL) for 6 h. Cell lysates were prepared for measuring firefly and renilla luciferase 
activities in GloMax 20/20 luminometer (Promega) using dual luciferase reporter assay 
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system as per manufacturer’s instructions (Promega). Firefly luciferase units were 
normalized with renilla luciferase units. Relative luciferase units were calculated by 
dividing normalized firefly luciferase units measured from stimulated cells with those 
measured from unstimulated cells.  
Plasmids and site-directed mutagenesis 
pIHA-Nsp1∆268-297 plasmid was constructed by deleting thirty amino acids 
from 268 to 297 amino acid positions in the whole Nsp1 sequence (Gene Bank Accession 
No. AY545985). Plasmids expressing authentic Nsp1α or Nsp1β (pIHA-Nsp1α and 
pIHA-Nsp1β (164)) were used to introduce 3-6 amino acid alanine-scanning mutations. 
pIHA-Nsp1∆268-297 plasmid was used to introduce point mutations in Nsp1α. Mutations 
were introduced into Nsp1 genes by PCR mutagenesis following the mega primer method 
(151). The primers used in PCR mutagenesis are listed in Table 1a. The plasmids, 
pswTNFα-luc, 5XSp1RE-luc, pGal4RE-luc, pCDNA3.1+Gal4-Sp1TAD, were described 
previously (164).  
pCDNA3.1+TNFαIRESGFP plasmid was constructed by cloning swine TNF-α 
cDNA (GenBank Accession No. NM_214022.1) in pCDNA3.1+ followed by 
downstream cloning of IRES-eGFP sequences derived from pIRES2-eGFP (Clontech). 
An internal hemagglutinin (HA) epitope tag was added in frame at amino acid position 
183 in TNF-α coding sequence to facilitate its staining. 
In vitro TNF-α translation assay  
BHK-21 cells were grown on coverslip for 24 h before transfection. Cells were 
transfected with pCDNA3.1+TNFαIRESGFP (1µg) plasmid along with either control 
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vector or non-structural protein expressing plasmids (1µg) using lipofectamine 2000 
(Invitrogen). After 18 h post-transfection, cells were subjected to confocal 
immunofluorescence staining to detect the protein expression and intracellular 
localization. A positive hit in this assay is a viral protein that down-modulated TNF-α 
expression without affecting GFP expression. 
Quantitative RT-PCR and ELISA 
 TNF-α-specific quantitative PCR (qPCR) was performed as previously described 
(164). Briefly, total RNA fractions were prepared from mock-infected cells or cells 
infected with either vFL12 or mutant viruses using Trizol-LS reagent (Invitrogen). 
Complementary DNAs (cDNAs) were synthesized with 1-2µg total RNAs using oligo-
dTs as reverse primer.  cDNAs (1 µL) were used as template in qPCR reactions for TNF-
α or β-actin to measure respective mRNAs using sequence-specific primers and probes 
(164).  
PRRSV 3’untranslated region (UTR)-specific qRT-PCR was performed to detect 
viral RNAs in serum of infected pigs. Briefly, viral RNAs were isolated from 140 µL of 
serum using QIAamp viral RNA mini kit (Qiagen). Viral RNAs (4µL) were used as 
template in quantitative reverse-transcription (RT)-PCR reaction using hot start-IT Probe 
one step qRT-PCR kit (USB, 75772). The following primers and probe were used in the 
reaction: forward primer ATGTGTGGTGAATGGCACTG, reverse primer 
GCATGGTTCTCGCCAATTAAA, Taqman probe 6-FAM-TCACCTATTCAATTAGG 
GCGACCG-TAMRA. The cycling conditions employed were as follows: reverse 
transcription at 50
○
C for 30 min, initial enzyme activation at 95
○
C for 2 min, denaturation 
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at 95
○
C for 15 sec followed by annealing/extension at 60
○
C for 60 sec. Denaturation and 
annealing/extension steps were repeated for total of 45 cycles. 
To measure the TNF-α protein levels in the supernatant of mock-infected or virus-
infected cells, a commercial swine TNF-α-specific ELISA was used (Pierce /Invitrogen).  
Semi-quantitative reverse-transcription PCR 
 The mRNAs for CCL2, CXCL-10, TNF-α-IRES-GFP, Nsp1α, GAPDH, and 
Cyclophilin were quantified by semi-quantitative RT-PCR. Total RNAs were prepared 
from mock-infected, vFL12 wild type or mutant virus-infected cells using Trizol-LS 
reagent (Invitrogen). cDNAs were prepared from 1-2µg total RNAs using oligo-dT as 
reverse primers. The primers used in the PCR reactions were mentioned in Table 1b. The 
contents of PCR reaction include: 1 µL of cDNA template,  2.5µL 10x Amplification 
Buffer, 1.25µL of forward or reverse primers (12.5 pmoles each), 0.5µL of 10mM dNTPs, 
0.25µL of Taq DNA polymerase (New England Biolabs), 19.5µL autoclaved distilled 
water. The thermal set up was as follows: initial denaturation at 95
○
C for 45 sec, 
annealing at 55
○
C for 30 sec, extension at 72
○
C for 1 min, for 25 cycles followed by final 
extension at 72
○
C for 5 min. The PCR products for each gene were normalized with the 
internal control, GAPDH or Cyclophilin before loading into 1% agarose gel 
electrophoresis.  
Confocal immunofluorescence  
 Transfected BHK-21 cells on coverslip were fixed with 4% paraformaldehyde for 
15 min at room temperature (RT) and washed thrice with PBS. Cells were then blocked 
with 3% bovine serum albumin (BSA) and 10% normal donkey serum (prepared in PBS 
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Tween20 (0.05%)) for 1 h at RT. After incubating with anti-HA mouse monoclonal 
antibody (1:100 dilutions, Covance) for 1 h at RT, cells were washed with PBS-Tween20 
for 5 min thrice. Cells were then incubated with donkey Alexafluor 568-conjugated anti-
mouse IgG (1:200 dilutions, Invitrogen) for 1 h at RT and washed thrice with PBS-
Tween20.  
After cell surface staining for TNF-α, intracellular staining for non-structural 
proteins was performed.  Cells were permeabilized with 0.15% saponin (prepared in 
PBS) for 10 min at RT. Intracellular blocking was performed using 3% BSA and 10% 
normal donkey serum (prepared in 0.15% saponin) for 1 h at RT. All subsequent washing 
and antibody-incubation steps were performed using 0.15% saponin prepared in PBS. 
After blocking, cells were incubated with anti-flag rabbit polyclonal antibody (1:100 
dilutions, Sigma) for 1 h at RT. Cells were then washed thrice and incubated with donkey 
Alexafluor 350-conjugated anti-rabbit IgG (1:200 dilutions, Invitrogen) for 1 h at RT. 
After washing thrice, cells on cover slips were mounted on glass slides using aqueous gel 
mounting medium (DAKO).  
 Intracellular TNF-α together with flag non-structural protein staining was carried 
out as follows: cells were fixed with 4% paraformaldehyde for 15 min at RT, washed and 
permeabilized with 0.15% saponin for 10 min at RT. After blocking, cells were incubated 
with primary and secondary antibodies followed by mounting as described above.   
For all cases, images were acquired using confocal laser scanning microscope 
(CLSM) (Olympus IX 81, Inverted Confocal Microscope) at 405nm (for Alexafluor 350), 
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488nm (for GFP) and 543nm (for Alexafluor 568) excitation laser filters. All images 
were taken with 60X magnification with same settings in sequential mode. 
Western blotting analysis 
Cellular protein lysates were prepared in either radio-immuno-precipitation assay 
buffer or cell-lysis buffer as described elsewhere (2, 10). The total protein content was 
measured using Protein Assay Kit I (Biorad). Equal amounts of protein were resolved in 
12% Sodium dodecyl Sulfate (SDS)-polyacrylamide gel electrophoresis and transferred 
on Polyvinylidene fluoride (PVDF) membrane by semi-dry blotting. The membranes 
were blotted with rabbit polyclonal antibodies specific for Nsp1 or mouse monoclonal 
antibodies specific for β-actin (Santacruz) or HA (Sigma) or GFP (Santacruz) for 
overnight at 4
○
C. The membranes were treated with Horse Radish Peroxidase (HRP)-
conjugated anti-rabbit or anti-mouse IgG antibodies (KPL) for 1 h at RT and signals were 
obtained with chemiluminescence substrates (Thermo scientific).   
Construction of mutant FL12 infectious clones and recovery of mutant viruses 
 In order to transfer Nsp1α and Nsp1β mutant sequences from pIHA constructs 
into FL12 infectious clone, we constructed an intermediate transfer vector pIHA-2757. 
The plasmid was constructed by cloning RsrII and SpeI restriction-digested fragment of 
pFL12 infectious clone into pIHA empty vector (10). Nsp1α mutant sequences were 
cloned into pIHA-2757 using AccI and StuI restriction sites present within Nsp1α.  Nsp1β 
mutant sequences were cloned into pIHA-2757 using AvrII and BsrGI restriction sites 
present within Nsp1β. Finally, the RsrII and SpeI digested fragment was transferred from 
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the pIHA-2757 mutant plasmid into pFL12 infectious clone. The corresponding mutation 
in pFL12 plasmid was confirmed by sequencing.  
For in vitro transcription, the mutant pFL12 was linearized using AclI enzyme and 
gel purified. Capped in vitro transcripts (IVTs) were subsequently prepared from 
linearized pFL12 template using mMessage mMachine T7 ultra kit (Ambion) and 
purified by phenol-chloroform extraction method. Purified IVTs were checked in agarose 
gel electrophoresis for integrity and quality.  Finally, IVTs were electroporated into 
MARC-145 or BHK-21 cells using Gene pulser Xcell electroporator (Biorad). Cells were 
electroporated in DMEM containing 1.25% DMSO and immediately placed in recovery 
medium (DMEM supplemented with 10% FBS and 1.25% DMSO). After 1-2 days post-
electroporation, the replication of mutant virus was confirmed by immunofluorescence 
using anti-N monoclonal antibodies (SDOW17, NVSL-USDA). The success of viral 
recovery was assessed by spread of cytopathic effect in electroporated MARC-145 cells. 
The supernatants from electroporated BHK-21 cells were transferred on to PBMC-
derived macrophages to propagate recovered viruses. 
Multi-step growth kinetics of viruses 
 For multi-step growth kinetics, MARC-145 cells were cultured in 96-well plates 
two days before infection. On the third day, cells were infected with vFL12 wild type or 
mutant viruses at 0.1 multiplicity of infection (m.o.i.) in triplicates. At 6, 12, 24, 48, 72, 
96 h post-infection, supernatants were collected and viruses were titrated in MARC-145 
cells. The viral titers were calculated using Reed and Muench method (140).  
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Viral infection studies in macrophages  
For measuring TNF-α mRNA and protein responses, PBMC-derived macrophages 
were infected with vFL12 wild type or mutant viruses at 0.1 m. o. i. At 12, 24, 36 and 48 
h post-infection, cells were collected in Trizol-LS (Invitrogen) for mRNA quantification. 
Supernatants were collected to measure TNF-α protein and viral titers. 
 Pig infection studies 
 PRRSV-negative pigs (n=3 each group) were infected with vFL12 wild type or 
mutant strains at 10
5.1
 TCID50/ 2 mL intra-muscularly. At 3, 7, 10, 14, 21 days post-
infection (dpi), serum was collected to determine viremia and TNF-α protein levels by 
viral titration and ELISA, respectively. 
RESULTS 
Cysteine protease activities of Nsp1α and Nsp1β are not necessary for TNF-α 
promoter suppression 
 Nsp1α and Nsp1β cysteine protease activities are mediated by papain-like 
cysteine protease domain α (PCPα) and papain-like cysteine protease domain β (PCPβ) 
respectively (87). The histidine residue at amino acid position 146 in Nsp1α is part of 
PCPα active site (87). Similarly, the cysteine residue at amino acid position 90 and the 
histidine residue at amino acid position 159 are part of the PCPβ active site (87). 
Mutating these residues in expression constructs did not affect their respective protein 
levels (Fig 1a, 1b). Subsequently, transient reporter assays were carried out with a TNF-α 
promoter-luciferase construct and LPS was used to stimulate the promoter. The PCPα and 
PCPβ active site mutant proteins efficiently reduced the TNF-α promoter activity when 
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compared to wild type protein (Fig 1a, 1b). The data suggested that Nsp1α and Nsp1β 
reduced the TNF-α promoter activity independently of their cysteine protease activities. 
Nsp1α cysteine protease domain is involved in TNF-α promoter suppression 
 Nsp1α has two distinct domains, zinger finger (ZF) domain (1-65 amino acids) 
and PCPα domain (66-166 amino acids) (166). To identify which of these domains 
necessary for reducing TNF-α promoter activity, I performed alanine scanning 
mutagenesis in randomly selected blocks of 4-6 amino acid length spanning the Nsp1α 
protein. In transient reporter assays, all PCPα domain mutants were unable to reduce 
TNF-α promoter activity (Fig 2a). Certain PCPα domain mutants such as, Nsp1α122-6A, 
Nsp1α139-5A, and Nsp1α155-5A had reduced protein levels when compared to the wild 
type protein (Fig 2a). In contrast, three out of four ZF domain mutants reduced the TNF-α 
promoter activity similar to the wild type protein (Fig 2a). The other ZF domain mutant 
(Nsp1α41-5A) suppressed the TNF-α promoter less efficiently than the wild type protein, 
which may be due to reduced protein expression (Fig 2a). Additional mutations of three 
amino acid blocks in Nsp1α relieved TNF-α promoter suppression only if present in 
PCPα domain but not in ZF domain (Fig 2b). In summary, the PCPα domain was 
important for reducing TNF-α promoter activity. 
Identification of amino acid residues of PCPα domain critical for TNF-α promoter 
suppression 
Additional studies were performed to identify individual amino acid residues in 
PCPα domain necessary for reducing TNF-α promoter activity but not its own cysteine 
protease activity. Point mutations were introduced at selected amino acid residues within 
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positions 89-127 in an Nsp1Δ268-297 gene construct. Full-length Nsp1Δ268-297 is 
expected to be auto-cleaved into wild type Nsp1α and deletion mutant Nsp1βΔ88-117 by 
cis-acting PCPα protease activity. Nsp1α but not Nsp1βΔ88-117 reduced the TNF-α 
promoter activity in cells transfected with Nsp1Δ268-297 gene construct (data not 
shown). Therefore, PCPα mutations in this construct may affect two functions of Nsp1α: 
TNF-α promoter suppression and/or PCPα protease activity in transient transfection 
assays. 
Mutation at Nsp1α amino acid residues, Gly90, Asn91, Arg97, Arg100, and 
Arg124 reduced TNF-α promoter activity less efficiently when compared to the wild type 
protein (Fig 2c, 2d, 2e). Mutations at these amino acid residues did not affect PCPα 
protease activities as judged by migration of Flag-Nsp1α at approximately 22KDa size 
(Fig 2c, 2d, 2e). Mutation at Nsp1α amino acid residues, Gln95 and Val99 reduced TNF-
α promoter activity more efficiently when compared to the wild type protein (Fig 2c, 2d). 
Analysis of Nsp1α tertiary structure revealed that the amino acid residues, Gly90, Asn91, 
Arg97, Arg100, and Arg124 are closely positioned on PCPα domain surface (Fig 2f). In 
summary, five amino acid residues in PCPα domain, Gly90, Asn91, Arg97, Arg100, and 
Arg124 are important for reducing the TNF-α promoter activity but not its protease 
activity. 
Mutations in all Nsp1β domains relieved TNF-α promoter suppression 
 Nsp1β has three domains, an N-terminal nuclease domain (1-48 amino acids), a 
flexible linker domain (49-84 amino acids) and a C-terminal PCPβ domain  (85-181 
amino acids) (201). To identify the domains involved in reducing TNF-α promoter 
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activity, alanine scanning mutations of 4-6 amino acids in all Nsp1β domains were 
introduced. In transient reporter assays, most mutant proteins relieved TNF-α promoter 
suppression activities approximately 50% relative to the wild type protein (Fig 3a). The 
mutants, Nsp1β124-4A and Nsp1β136-5A, had reduced protein levels when compared to 
the wild type protein (Fig 3a). The data suggested that all Nsp1β domains were necessary 
for inhibiting TNF-α promoter activity. 
Recovery of Nsp1α and Nsp1β mutant viruses by reverse genetics system 
 In the case of Nsp1α, attempts were made to recover viruses harboring 3-6 amino 
acid block mutations by reverse genetics. Viruses with mutations at the Nsp1α positions, 
89-93, 95-97, 97-100, and 122-127 were non-viable as judged by anti-N (PRRSV 
nucleopcapsid) immunofluorescence (Table 2). However, viruses were recovered with 
mutations at Nsp1α amino acid residue, Gly90 (Gly90Ala and Gly90Ser, respectively 
designated as vFL12Nsp1αG90A and vFL12Nsp1αG90S) (Table 2). Viruses harboring 
mutations at Nsp1α amino acid residues, Asn91, Arg97, Arg100, and Arg124 were not 
viable (Table 2). 
 In the case of Nsp1β, attempts were made to generate viruses with mutations at 
Nsp1β positions, 70-74 and 113-118. The infectious virus was successfully recovered 
with mutations between positions 70-74 (named vFL12Nsp1β70-5A) but a viable virus 
was not recovered with mutation between positions 113-118 (Table 2).   
Repeated attempts to recover viruses harboring mutations in both Nsp1α Gly90 
and Nsp1β 70-74 positions simultaneously led to failure. In summary, we recovered three 
mutant PRRSVs, two having mutations in Nsp1α at Gly90 (Gly90Ala, Gly90Ser) and one 
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having mutation in Nsp1β at position, 70-74. For further experiments, of the two Nsp1α 
mutant viruses, we selected the one having maximum nucleotide substitutions (Gly90Ser).  
The Nsp1β70-5A mutant protein did not disrupt Sp1 reporter activities in transient 
transfection assays 
My previous findings indicate that Nsp1β reduces TNF-α promoter activity, in 
part by inhibiting Sp1 trans-activation (164). Since a virus was recovered carrying a 
mutation in Nsp1β (Table 2), studies were carried out to determine whether the 
corresponding mutant protein suppressed Sp1-dependent transcription. In transient 
reporter assays that measure the activities of endogenous Sp1, the Nsp1β70-5A mutant 
protein did not reduce Sp1-dependent reporter expression in transfected cells (Fig 4a). 
Similarly, in trans-activation assays that measure the function of Sp1 transactivation 
domain, the Nsp1β70-5A mutant protein did not suppress Sp1 trans-activation required 
for reporter expression (Fig 4b). In conclusion, Nsp1β amino acids at position 70-74 were 
necessary for inhibiting the Sp1-dependent transcription, including the TNF-α promoter.  
Nsp1α reduces TNF-α protein levels in an in vitro translation assay  
 My previous findings suggest that PRRSV decreases TNF-α production by 
reducing the promoter activity and by an unknown post-transcriptional mechanism (164). 
Studies to identify viral protein(s) that inhibited TNF-α at the post-transcriptional level 
were undertaken using an in vitro TNF-α translation reporter system (Fig 5a). Non-
structural proteins and N protein of PRRSV were tested for their ability to reduce TNF-α 
protein levels in in vitro translation assays. Nsp1α only reduced TNF-α protein levels in a 
specific manner that is without down modulating the bi-cistronic translation control, GFP 
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(Fig 5b, 5c and 5d). Nsp1α up regulated Internal Ribosome Entry site (IRES)-dependent 
GFP translation when compared to the control (Fig 5d). Moreover, Nsp1α did not affect 
TNF-α-GFP bi-cistronic mRNA levels when compared to the control (Fig 5e). These 
results suggested that in addition to its effect on the promoter, Nsp1α also suppressed 
TNF-α expression by a post-transcriptional mechanism. 
Gly90 residue was essential for efficient reduction of TNF-α protein levels by Nsp1α  
Since viruses were recovered carrying mutations in Nsp1α (Table 2), studies were 
performed to test whether corresponding mutant proteins can reduce TNF-α levels post-
transcriptionally. The mutant proteins, Nsp1αG90A and Nsp1αG90S, reduced TNF-α 
protein levels less efficiently when compared to the wild type protein (Fig 5d). Further, 
the Nsp1αG90 mutant proteins did not affect TNF-α-GFP bi-cistronic mRNA levels 
when compared to the wild type protein (Fig 5e). Therefore, Nsp1α Gly90 residue was 
necessary for efficient suppression of the TNF-α production via a post-transcriptional 
mechanism. 
Growth characteristics and plaque morphology of PRRSV mutant viruses 
 Multi-step growth kinetic analysis revealed that both mutant viruses 
(vFL12Nsp1αG90S and vFL12Nsp1β70-5A) exhibited moderate growth defect in 
cultured MARC-145 cells when compared to the wild type vFL12. In particular, the 
vFL12Nsp1β70-5A virus grew slower than vFL12 virus by a 1.0-1.5 log difference in 
titers (Fig 6a). The vFL12Nsp1αG90S virus had a 0.5-1.0 log difference in titers when 
compared to vFL12 (Fig 6a).  Both mutant viruses also exhibited reduced plaque sizes 
when compared to the wild type virus (Fig 6b). These results suggested that the Nsp1 
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mutant viruses, vFL12Nsp1αG90S and vFL12Nsp1β70-5A, had reduced growth in 
cultured MARC-145 cells. 
Nsp1 mutant viruses induced TNF-α expression stronger than the wild type virus in 
infected macrophages 
Studies were then performed to examine TNF-α responses after infecting swine 
macrophages with vFL12 wild type or the mutant viruses. Infections with Nsp1 mutant 
viruses induced higher levels of TNF-α mRNAs only at 12 h post-infection when 
compared to the infection with wild type virus (Fig 7a). However, there were no 
differences observed in TNF-α mRNA levels between wild type and mutant virus 
infected macrophage cultures at 24 h post-infection (Fig 7a). Noticeably, the cultures 
infected with the mutant vFL12Nsp1β70-5A induced significant TNF-α mRNA levels as 
early as 12 h post-infection (Fig 7a). 
Both wild type vFL12 and mutant vFL12Nsp1β70-5A viruses induced negligible 
levels of TNF-α protein in the supernatant of infected macrophage cultures (Fig 7b). 
However, the mutant vFL12Nsp1αG90S virus induced higher levels of TNF-α in the 
supernatant of infected macrophage cultures both at 12 and 24 h post-infection (Fig 7b). 
Furthermore, the mutant viruses, vFL12Nsp1β70-5A and vFL12Nsp1αG90S replicated 
with low viral titers in macrophage cultures after infection when compared to wild type 
vFL12 (Fig 7c). In particular, the mutant vFL12Nsp1β70-5A showed two log10 reduced 
viral titers in macrophage culture supernatants after infection when compared to vFL12 
(Fig 7c).  
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Macrophages infected with both mutant viruses also induced higher levels of two 
chemokines, CCL2 and CXCL10, at 24 and 36 h post-infection when compared to 
macrophages infected with vFL12 (Fig 7d). This was expected because these two 
chemokines are known to be induced by TNF-α (120, 138).  In summary, the mutant 
viruses, vFL12Nsp1αG90S and vFL12Nsp1β70-5A, stimulated the production of TNF-α 
mRNA and protein stronger than the wild type vFL12 in infected macrophage cultures.  
In vivo attenuation and TNF-α induction phenotype of PRRSV mutant viruses in 
infected pigs 
To examine the growth of the Nsp1 mutant viruses and TNF-α responses in swine, 
pigs were infected with wild type vFL12 or the mutant viruses. At 14 days post-infection 
(dpi), all infected pigs were positive for PRRSV-specific antibodies (Fig 8d). 
Furthermore, all infected pigs exhibited peak viremia between 3-7 days post-infection 
(Fig 8a, 8b). When compared to wild type vFL12, the mutant vFL12Nsp1β70-5A showed 
two log10 reduced viral titers and viral RNA copies in serum at 3 dpi (Fig 8a, 8b). By 7 
dpi, two out of three animals infected with the mutant vFL12Nsp1β70-5A had no 
detectable infectious virus in serum (Fig 8a). However, viral RNAs were detected at 
lower levels in pigs infected with the mutant vFL12Nsp1β70-5A when compared to pigs 
infected with vFL12 for 14 days (Fig 8b). In contrast, pigs infected with the mutant 
vFL12Nsp1αG90S had similar viral titers as well as viral RNA copies in serum when 
compared to the pigs infected with vFL12 (Fig 8a, 8b).  
Pigs infected with the mutant vFL12Nsp1αG90S showed increased TNF-α protein 
levels in serum at 7 dpi when compared to pigs infected with wild type vFL12 (Fig 8c). 
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However, at 10 dpi, both vFL12 and vFL12Nsp1αG90S groups had similar elevated 
levels of TNF-α (Fig 8c). In contrast, TNF-α protein levels in serum did not increase in 
pigs infected with vFL12Nsp1β70-5A virus at any time after infection (Fig 8c). These 
results suggested that the mutant vFL12Nsp1β70-5A virus was attenuated in infected pigs.  
DISCUSSION: 
  PRRSV decreases the production of TNF-α during infection in vitro and in vivo 
(20, 92, 102, 164, 184). Nsp1α and Nsp1β are important viral mediators that reduce TNF-
α promoter activity in transient transfection assays (164). In this study, I identified critical 
amino acid residues in Nsp1α and Nsp1β that are important for TNF-α suppression. 
Subsequently, through reverse genetics, I generated two mutant PRRSV viruses that up 
regulated TNF-α expression in macrophage cultures after infection. These two mutant 
viruses replicated at lower levels in the cell culture and strongly stimulated TNF-α-
induced chemokines.  In infected pigs, one mutant virus with mutation in Nsp1β was 
attenuated in growth. Moreover, Nsp1α reduced TNF-α protein levels by a post-
transcriptional mechanism.  
Several laboratories demonstrated that PRRSV infection leads to poor TNF-α 
response in serum and broncho-alveolar lavage fluid from infected pigs (92, 173, 184).  
Similarly, PRRSV infection actively inhibits TNF-α expression in macrophages and 
dendritic cells in vitro (20, 102). Previous results from our laboratory indicated that 
PRRSV cysteine proteases, Nsp1α and Nsp1β suppress TNF-α promoter by modulating 
the activity of specific transcription factors (164). In this study, I sought to characterize 
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the amino acid residues in Nsp1α and Nsp1β that reduce TNF-α and recover PRRSV 
strains with mutations in those positions by reverse genetics.  
Previous reports found that active site mutations in Nsp1 cysteine proteases lead 
to failure of virus recovery by reverse genetics (87). My results showed that the Nsp1 
cysteine protease activities were not necessary for reducing TNF-α promoter activity. 
This observation is consistent with previous findings that the Nsp1 cysteine proteases 
cleave only cis-substrates present at the end of respective proteins (166, 201). Therefore, 
it is less likely that Nsp1 cysteine protease activities degrade signaling molecules 
required for the TNF-α-induction pathway.  
Further studies with domain-specific mutations showed that the PCPα domain, not 
the ZF domain was important for inhibiting TNF-α promoter activity. Five amino acid 
residues (Gly90, Asn91, Arg97, Arg100, and Arg124) on the surface of the PCPα domain 
were important for inhibiting the TNF-α promoter. Many mutations in the ZF domain of 
Nsp1α did not significantly relieve TNF-α suppression, which suggested the ZF domain 
was not important.  
Mutant viruses with mutation at Nsp1α Gly90 residue were only recovered. But, 
viruses with mutation at residues, Asn91, Arg97, Arg100, and Arg124, apparently were 
not viable. Since these mutations did not affect PCPα protease function, the amino acids 
may be important for other functions, viral transcription and virion biogenesis (53). This 
notion is further supported by my observation that Asn91, Arg97, Arg100 and Arg124 
are well conserved across both PRRSV genotypes.  
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Unlike Nsp1α, all three domains of Nsp1β were important for reducing TNF-α 
promoter activity. One of Nsp1β mutants (70-5A) has protein levels equivalent to wild 
type but did not reduce TNF-α promoter activity efficiently. The 70-5A mutation is 
located in small linker domain of Nsp1β. The successful recovery of mutant virus in this 
position suggests that the amino acids at 70-74 position are not required for Nsp1β 
protease activity over Nsp1β-Nsp2 junction. The results also indicated that the Nsp1β70-
5A mutant protein did not suppress Sp1 trans-activation activity, which is necessary for 
activating the TNF-α promoter (52). It is plausible that the Nsp1β linker domain may 
directly participate in the inhibition of Sp1 trans-activation or indirectly modulate the 
functions of the other Nsp1β domains to inhibit Sp1-dependent TNF-α transcription.  
Previous studies demonstrated that PRRSV possess an additional mechanism to 
suppress TNF-α at post-transcriptional levels (164, 173). Hence, even if Nsp1 mutant 
viruses could not inhibit TNF-α promoter activity, they might fail to induce TNF-α 
protein levels during infection. Eventually, I was interested to find the proteins that 
inhibit TNF-α at a post-transcriptional level. Using an in vitro translation assay, over-
expression of Nsp1α suppressed intracellular and cell surface TNF-α levels. As expected, 
Nsp1α did not affect GFP levels translated from same bi-cistronic mRNA in an IRES-
dependent manner.  This suggested that Nsp1α directly inhibited cap-dependent TNF-α 
translation or induced TNF-α degradation after translation.  
Recently, a cellular protein kinase, Pak2 was shown to interfere with cap-
dependent translation without affecting IRES-dependent translation (101). Pak2 
phosphorylates ribosomal initiation factor, eIF4G to inhibit cap-dependent translation 
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(101). If Nsp1α inhibits cap-dependent translation specifically, Pak2 may be an 
interesting candidate for Nsp1α to target this pathway in infected cells. If this were true, 
the cap-dependent translation of viral sub-genomic RNAs would also be affected during 
PRRSV infection. Hence, it is likely that Nsp1α degraded TNF-α after translation.   
When the growth characteristics of Nsp1 mutant viruses were examined, both 
viruses were moderately attenuated in susceptible MARC-145 cells, which may be due to 
attenuation of other Nsp1 functions such as transcription and replication. When we 
examined the growth of these mutant viruses in macrophages in vitro and in infected pigs, 
the growth of vFL12Nsp1β70-5A was severely compromised but the growth of 
vFL12Nsp1αG90S was slightly reduced. Macrophages can strongly activate innate 
immune pathways including TNF-α induction pathway during viral infection. It is 
plausible that the attenuation of Nsp1 mutant viruses in macrophages in vitro and in 
infected pigs was partially the result of stimulating immune responses, including TNF-α. 
My previous finding concluded that PRRSV inhibited the TNF-α transcription 
during early time points after infection in macrophages (164). I confirmed this finding in 
the present study. Although both Nsp1 mutant virus infections showed enhanced TNF-α 
transcriptional activity at early 12 h post-infection, only vFL12Nsp1αG90S mutant virus 
infection produced detectable levels of TNF-α protein in macrophages. In agreement with 
this finding, vFL12Nsp1αG90S mutant virus also induced TNF-α in serum of infected 
pigs at 7 dpi when compared to wild type vFL12 infected pigs. Likewise, Nsp1α Gly90 
mutant proteins did not efficiently reduce TNF-α protein levels in in vitro translation 
assays. Thus, Nsp1α reduced TNF-α protein levels via a post-transcriptional mechanism, 
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in addition to reducing the promoter activity. However, Nsp1β primarily involved in 
reducing TNF-α promoter activity.  
The overall conclusions of this study are as follows: 1) Nsp1α amino acid residue, 
Gly90 is necessary for reducing TNF-α promoter activity and TNF-α protein levels via a 
post-transcriptional mechanism during PRRSV infection. 2) Nsp1β amino acid residues 
between positions, 70 and 74 are necessary for reducing TNF-α promoter activity, in part 
by inhibiting the Sp1 transcription factor. 3) The above mentioned Nsp1α and Nsp1β 
amino acid residues are also necessary for reducing the expression of TNF-α-inducible 
chemokines. 4) The mutant virus with mutation at Nsp1β positions, 70-74 is greatly 
attenuated in infected pigs, which may be a good candidate for the development of 
attenuated live vaccines.  
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Table 1a. Primers used in site-directed mutagenesis 
 
Primer  Sequence (5’ to 3’) 
Nsp1-F ATATATCTCGAGATGTCTGGGATACTTGATCGG 
Nsp1-R  ATATATGCGGCCGCTTAACCGTACCATTTGTGACTGC 
Nsp1β-F ATATATCTCGAGGCTGACGTCTATGATATTGGTCATG 
Nsp1α-R ATATATGCGGCCGCTTACATAGCACACTCAAAAGGGCA  
nsp1Δ268-297-F GCTAATACTGTCCCTGAAAAGCATGGTGTCGCTGG 
nsp1α-20-4A-R CTGAGACATCGTGTGCAGTAGGCTGCGGCGGCCGCCATAAACACCCTGGCAT 
nsp1α-41-5A-R AAAATAGGCCCAGCACTGCAGCGGCAGCAGCTTGGAGATTCAGAGGAAG  
nsp1α-55-5A-R GGGGAATGCACGTGGCAACGTGGCGGCGGCTGCGGCTTCGGGCCTGTAAAATAGGC 
nsp1α-63-5A-R CGGGGGAGCACTCAACAGCGGCGGCTGCAGCTGGCAACGTCCACCGGAG 
nsp1α-89-5A-F CCAATTGCACGAATGACCGCTGCAGCCGCCGCCTTTCAACAAAGAATGGTGCGG 
nsp1α-97-4A-F TTCAACAAAGAGCAGCCGCAGCCGCAGCTGAGATTTA 
nsp1α-122-6A-F GAAGGCTCTACAAGTTGCTGCAGCAGCTGCCGCCTGGTACCCTATAGTC 
nsp1α-139-5A-F CCCTGGAGTGGCCGCTGCTGCCGCCGCCCTACATGTGAGTGA 
nsp1α-155-5A-F TTCCCGGGAGCAGCTGCTGCAGCAGCCAACCTGCCACTC 
nsp1α-32-3A-R CAGAGGAAGGGCAGCGGCTGCACTGA 
nsp1α-38-3A-R CCAAGCTCAGGAACTGCGGCAGCCAGAGGAA 
nsp1α-52-3A-R CCACCGGAGTGGCTCTGCGGCGGCGTAAAATAGGC 
nsp1α-86-3A-R CAGGTTTCCACTGGCGGCTGCTGCAATTG 
nsp1α-93-3A-F GGAAACCTGAACTTTGCAGCAGCAATGGTGCGGG 
nsp1α-105-3A-F GCGGGTCGCAGCTGCCATTGCCGCAGCCGGCCA 
nsp1α-117-3A-F GCAGTCTTGGCCGCTGCAGCAGTTTATGAAC 
nsp1α-148-3A-F CCCTACATGTGGCTGCTGCACCTTTCCCGG 
nsp1αS89A-F GCACGAATGACCGCTGGAAACCTGAA 
nsp1αG90A-F GACCAGTGCAAACCTGAACTTTC 
nsp1αG90S-F GCACGAATGACCAGTTCAAACCTGAACTTTC 
nsp1αN91A-F GACCAGTGGAGCCCTGAACTTTCAAC 
nsp1αL92A-F GACCAGTGGAAACGCGAACTTTCAAC 
nsp1αN93A-F GGAAACCTGGCCTTTCAACAAAGAAT 
nsp1αQ95A-R CCCGCACCATTCTTTGTGCAAAGTTCAGGTTTCCACT 
nsp1αQ96A-R GCTGCGACCCGCACCATTCTTGCTTGAAAGTTCAGGTTTCC 
nsp1αR97A-R GCTGCGACCCGCACCATTGCTTGTTGAAAGTTCAGGTT 
nsp1αV99A-F CAACAAAGAATGGCGCGGGTCGCAGCTGAG 
nsp1αR100A-F CAACAAAGAATGGTGGCGGTCGCAGCTGAG 
nsp1αY122A-F CTACAAGTTGCTGAACGGGGTTGC 
nsp1αE123A-F CTACAAGTTTATGCACGGGGTTGCCG 
nsp1αR124A-F ACAAGTTTATGAAGCGGGTTGCCGCTG 
nsp1αG125A-F TTATGAACGGGCTTGCCGCTGGTA 
nsp1αC126A-F ATGAACGGGGTGCCCGCTGGTACCC 
nsp1αR127A-F GAACGGGGTTGCGCCTGGTACCCTAT 
nsp1β-16-5A-F CCGTCATGTATGTGGCCGCCGCTGCCGCCGCCTGGGCCCCTCGTGGC 
nsp1β-48-6A-R AGACATGTCCACTGCGGCGGCGGCGGCGGCGGCGATGTGGAGTTGGTTC 
nsp1β-70-5A-R CAGCCGTGTGGGCAGGCGGCGGCGGCAGCGACACCACTCCCAGG 
nsp1β-101-5A-F ACTCGCTCCCACTGGCCGCTGCCGCCGCAGAAATTCGCCGTGCCA 
nsp1β-113-6A-F TCGCCGTGCCAACCAAGCCGCCGCCGCAGCCGCCCATGGTGTCGCTGGC 
nsp1β-124-4A-F TGGTGTCGCTGGCGCCGCCGCAGCACGGAGGCTGCAAGC 
nsp1β-136-5A-F AAGCTAATGGTCTCGCAGCAGCCGCTGCTACAGATGGACCCATT 
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Table 1b. Primers used in semi-quantitative RT-PCR 
Primer  Sequence (5’ to 3’) 
hTNFa-F ATATATGCTAGCCACCATGAGCACTGAAAGCATG 
hTNFa-R ATATATGGATCCTCACAGGGCAATGATC 
GAPDH(+) CCATGGAGAAGGCTGGGG 
GAPDH(-) CAAAGTTGTCATGGATGACC 
CCL2-F GCTTGAATCCTCATCCTCCA 
CCL2-R AAGGCTTCGGAGTTTGGTTT 
IP-10-F TTCGCTGTACCTGCATCAAG 
IP-10-R AACAGCTCGGGATGATGAAC 
CYCROP-F TAACCCCACCGTCTTCTT 
CYCROP-R TGCCATCCAACCACTCAG 
 
Table 2. Recovery of PRRSV mutant viruses by reverse genetics 
Aminoacid position Anti-N 
Immunofluorescence 
Virus recovery 
Nsp1α (89-93) - - 
Nsp1α (95-97) - - 
Nsp1α (97-100) - - 
Nsp1α (122-127) - - 
Nsp1α Gly90Ala + + 
Nsp1α Gly90Ser + + 
Nsp1α Asn91Ala - - 
Nsp1α Arg97Ala - - 
Nsp1α Arg100Ala - - 
Nsp1α Arg124Ala - - 
Nsp1β (70-74) + + 
Nsp1β (113-118) - - 
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                           (a)                                       (b) 
 
Figure 1. PRRSV Nsp1α and Nsp1β suppress TNF-α promoter activity independent 
of their cysteine protease functions. RAW 264.7 cells were transfected with pswTNF-
luc plasmid (0.2µg) along with viral protein expressing plasmid (1µg) and a renilla 
luciferase expressing vector (10ng). After 24 h, cells were stimulated with LPS (1µg) for 
6 h. In cell lysates, firefly luciferase activities were measured and normalized with renilla 
luciferase activities. 100% TNF-α promoter activity represents the activity in control 
vector transfected cells and 0% promoter activity represents the activity in wild type 
Nsp1α or Nsp1β transfected cells. Each bar represents mean ± standard error (n=3). 
Bottom panels depict the amount of corresponding viral proteins in transfected cells. 
RAW 264.7 cells were transfected with viral protein expressing plasmid (2µg). After 24 h 
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post-transfection, the viral protein in cell lysates was detected by western blotting using 
anti-Nsp1 antibodies.  β-actin was used as loading control.  
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 (a) 
 
(b)  
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(c) 
 
   (d)                                  (e)                                 (f) 
                             
Figure 2. Characterization of Nsp1α amino acid residues necessary for reducing 
TNF-α promoter activity. (a-e) RAW 264.7 cells were transfected with pswTNF-luc 
(0.2µg) along with Nsp1α wild type or mutant protein expressing plasmid (1µg) and a 
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renilla luciferase expressing vector (10ng). After 24 h, cells were stimulated with LPS 
(1µg/mL) for 6 h. Firefly luciferase activities were measured in cell lysates and 
normalized with renilla luciferase activities. 100% TNF-α promoter activity represents 
the activity in control vector transfected cells and 0% promoter activity represents the 
activity in wild type Nsp1α transfected cells. Each bar represents mean ± standard error 
(n=3). The immunoblot panels depict the amount of corresponding viral proteins in 
transfected cells. RAW 264.7 cells were transfected with Nsp1α wild type or mutant 
protein expressing plasmid (2µg). After 24 h post-transfection, the viral protein in cell 
lysates was detected by western blotting using anti-Nsp1 antibodies.  β-actin was used as 
loading control.  (f) Tertiary structure of Nsp1α. Residues necessary for reducing TNF-α 
promoter activity are highlighted: Three arginine residues (in green), the glycine residue 
(in yellow) and the asparagine residue (in blue). The figure was adopted from NCBI 
structure database (PDB ID: 3IFU) using Cn3D software. 
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Figure 3. All domains of Nsp1β contribute to TNF-α promoter suppression. RAW 
264.7 cells were transfected with pswTNF-luc (0.2µg) along with Nsp1β wild type or 
mutant expressing plasmid (1µg) and a renilla luciferase vector (10ng). After 24 h, cells 
were stimulated with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in 
cell lysates and normalized with renilla luciferase activities. 100% TNF-α promoter 
activity represents the activity in control vector transfected cells and 0% promoter 
activity represents the activity in wild type Nsp1β transfected cells. Each bar represents 
mean ± standard error (n=3). Bottom panels depict the amount of corresponding viral 
proteins in transfected cells. RAW 264.7 cells were transfected with Nsp1β wild type or 
mutant expressing plasmid (2µg). After 24 h post-transfection, the viral protein in cell 
lysates was detected by western blotting using anti-Nsp1 antibodies.  β-actin was used as 
loading control. 
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 (a)                                                              (b)            
                 
 
Figure 4. Nsp1β70-5A mutant protein is unable to suppress Sp1-dependent 
transcription. (a) Sp1 reporter assay. RAW 264.7 cells were transfected with 5XSp1RE-
luc (0.2µg) along with wild type Nsp1β or mutant Nsp1β70-5A expressing plasmid (1µg) 
and a renilla luciferase expressing vector (10ng). After 24 h, Sp1 activity was stimulated 
with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in cell lysates and 
normalized with renilla luciferase activities. (b) Sp1 trans-activation assay. RAW 264.7 
cells were transfected with pGal4RE-luc (0.2µg) along with pCDNA3.1 expressing Gal4-
Sp1TAD fusion protein (1µg), plasmid expressing Nsp1β wild type or Nsp1β70-5A 
mutant (1µg) and renilla luciferase expression vector (10ng). After 24 h, cells were 
stimulated with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in cell 
lysates and normalized with renilla luciferase activities. The values in y-axis represent the 
firefly luciferase units obtained from stimulated cells relative to that obtained from 
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unstimulated control vector transfected cells. Each bar represents the mean ± standard 
error (n=3). In both panels, ‘control’ indicates cells transfected with empty expression 
plasmid only. In panel (a), ‘control+’ indicates cells transfected with empty expression 
plasmid along with 5XSp1RE-luc plasmid. In panel (b), ‘control+’ indicates cells 
transfected with empty expression plasmid along with pGal4RE-luc plasmid.  
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Figure 5. Nsp1α suppresses TNF-α protein expression and mutation at Gly90 
position partially relieves the suppression.  (a) Schematic diagram of the TNF-α 
translation reporter construct expressing under CMV promoter. The bi-cistronic gene 
construct (pCDNA3.1+TNFαIRESGFP) has two genes, swine TNF-α gene and GFP 
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under cap-dependent and IRES-dependent translation, respectively. A HA tag was 
internally inserted at amino acid position 183 of TNF-α. pA means poly-adenylation 
signal. (b, c) BHK-21 cells grown on cover slips were transfected with 
pCDNA3.1+TNFαIRESGFP (1µg) along with plasmid expressing Nsp1α (1µg). After 18 
h post-transfection, cells were fixed with 4% paraformaldehyde. For intracellular staining 
(b), cells were further permeabilized with 0.15% saponin. For cell surface staining (c), 
cells were stained first for cell surface before permeabilization for intracellular staining. 
Prior to primary antibody staining, cells were blocked with bovine serum albumin and 
normal donkey serum. TNF-α-HA was detected with mouse anti-HA antibody followed 
by staining with Alexafluor 568-conjugated secondary antibody. Flag-Nsp1α was 
detected with rabbit anti-flag antibody followed by staining with Alexafluor 350-
conjugated secondary antibody. All confocal images were captured with the same settings 
in sequential mode. iTNF means intracellular TNF-α and mTNF means cell surface TNF-
α. (d) BHK-21 cells grown on coverslips were transfected with pCDNA3.1+TNFαIRES 
GFP (1µg) along with plasmid expressing Nsp1α or mutant protein (1µg). After 24 h 
post-transfection, cell lysates were prepared for immunoblotting to detect Nsp1α, TNF-α-
HA, and GFP using specific antibodies against Nsp1, HA probe and GFP, respectively.  
β-actin was used as loading control. (e) BHK-21 cells were transfected with 
pCDNA3.1+TNFαIRESGFP (1µg) along with plasmid expressing Nsp1α or mutant 
protein (1µg). After 24 h post-transfection, total RNAs were prepared and cDNAs were 
synthesized. cDNAs were used as templates in semi-quantitative RT-PCR reactions using 
sequence-specific primers for TNF-α and Nsp1α. GAPDH was used as internal control.  
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 (a) 
 
(b)  
 
 
Figure 6. Nsp1 mutant viruses have reduced growth when compared to wild type 
vFL12 virus. (a) Multi-step growth kinetics in MARC-145 cells after infection with 0.1 
m. o. i. of indicated viruses. Supernatant of infected cells was collected at indicated time 
points and viral titration was performed in MARC-145 cells. Viral titers are expressed as 
tissue culture infectivity dose50 (TCID50). Viral titer values represent the mean ± standard 
error (n=3). (b) Plaque morphology of viruses in MARC-145 cells. Cells were infected 
with FL12 wild type or mutant viruses, covered with growth medium agar and incubated 
for 4 days. Cells were fixed with glutaraldehyde followed by crystal violet staining.  
vFL12                 vFL12Nsp1αG90S         vFL12Nsp1β70-5A 
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 (c) 
 
(d) 
                          
Figure 7. Effect of mutations in Nsp1 proteins on TNF-α as well as TNF-α inducible 
chemokines during PRRSV infection in vitro. (a)  Quantitative PCR analysis. PBMC-
derived macrophages were mock-infected or infected with 0.1 m. o. i. of indicated viruses. 
At different time points, total RNAs were prepared from infected cells and cDNAs were 
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synthesized. Using cDNAs as template, the amount of TNF-α mRNAs was quantified by 
qPCR. TNF-α copy numbers were calculated using standard curve prepared with known 
amount of templates and normalized with β-actin copy numbers.  Bars represent mean ± 
standard error (n=3). A p-value less than 0.05 was considered as significant. (b) TNF-α 
protein measurement by ELISA. PBMC-derived macrophages were infected with vFL12 
wild type or indicated mutant viruses at 0.1 m. o. i. TNF-α protein levels in the 
supernatant were measured by ELISA. Bars represent mean ± standard error (n=3). 
Dotted line in y-axis represents the detection limit of assay. (c) Viral titers were measured 
in MARC-145 cells and expressed as TCID50/mL. Mean ± standard error (n=3) values 
were shown. (d) Semi-quantitative RT-PCR analysis of TNF-α induced chemokines. 
PBMC-derived macrophages were infected with vFL12 wild type or mutant viruses. 
Total RNAs were prepared from infected cells and cDNAs were synthesized. RT-PCR 
reactions were performed using sequence-specific primers for CCL2 and CXCL10. 
Cyclophilin was used as internal control. 
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Figure 8. Comparison of viremia, TNF-α serum levels, and antibody responses 
between pigs infected with vFL12 wild type and pigs infected with mutant viruses. 
Four-week old piglets (n=3 each group) were infected intra-muscularly with 10
5.1
TCID50 
of vFL12 wild type or indicated mutant viruses. (a) Viral titers were evaluated in serum 
of infected pigs at indicated time points after infection. Viral titration was done in 
MARC-145 cells. The viral titers were calculated by Reed and Muench method, and 
expressed as tissue culture infectivity dose50 (TCID50/mL). Data indicate mean ± standard 
error (n=3). (b) PRRSV-specific quantitative RT-PCR analysis. Viral RNAs were 
isolated from serum of infected pigs at indicated time points after infection. They were 
quantified by qRT-PCR specific to vFL12 3’UTR as described in materials and methods. 
Viral RNA copies were calculated by using a standard curve prepared with known 
amount of templates. Data indicate mean ± standard error (n=3). (c) TNF-α ELISA. TNF-
α protein levels in serum of infected pigs were measured by ELISA at indicated time 
points after infection. Values are expressed as mean ± standard error (n=3). (d) PRRSV-
specific antibody responses. The amount of anti-N specific antibodies in serum of 
infected pigs was measured by IDEXX ELISA at 14 and 21 days post-infection. A signal-
to-positive (S/P) ratio ≥ 0.4 was considered as positive for PRRSV-specific antibodies. 
Bars represent mean ± standard error values (n=3). 
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CHAPTER IV 
 
 
A virulent strain of porcine reproductive and respiratory syndrome 
virus does not up-regulate interleukin-10 levels in vitro or in vivo 
 
 
Virus Research, 155: 415-422, 2011  
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ABSTRACT 
 Porcine reproductive and respiratory syndrome virus (PRRSV) causes 
reproductive failure and respiratory illness in infected pigs. It has been postulated that the 
ability of PRRSV to induce the anti-inflammatory cytokine interleukin-10 (IL-10) in 
macrophages of infected pigs would be important for PRRSV immunopathogenesis. 
However, several strains were reported to induce IL-10 in infected macrophages while 
others would not. In this study, we analyzed the IL-10 expression during in vitro and in 
vivo infections by a well characterized virulent strain of PRRSV, vFL12, which is derived 
from an infectious clone. Our results showed that the vFL12 strain did not up-regulate IL-
10 at mRNA or protein levels in either macrophages or dendritic cells after infection in 
vitro. Furthermore, immunofluorescence staining for IL-10 in tonsil sections of PRRSV-
infected pigs did not produce any evidence of IL-10 induction in PRRSV-infected cells or 
in bystander cells of the lymphoid tissues. We concluded that the induction of IL-10 
release is not a part of the PRRSV virulence mechanisms. 
Keywords: Interleukin-10, PRRSV, Virulence, Immunofluorescence, vFL12 
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INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus 
that causes syndrome characterized by a period of acute viremia followed by long-term 
persistence in infected pigs (3). During the course of this disease, PRRSV causes 
profound modulation of the homologous (PRRSV-specific) immune response which 
includes: weak induction of innate immune responses (1), delayed and weak neutralizing 
antibody responses (105) and weak cell-mediated immune responses, particularly IFN-γ 
responses (110). One of the mechanisms exploited by PRRSV to actively suppress the 
induction of immune response would be modulation of several key immuno-regulatory 
cytokines such as type I interferons, interleukin-1 (IL-1), tumor necrosis factor-alpha 
(TNF-α), interleukin-12 (IL-12), and interleukin-6 (IL-6) etc. in infected pigs (3, 102, 
173). Many viruses actively suppress the innate and adaptive immune responses by either 
up-regulating IL-10 or encoding viral homologs of IL-10 (139). Several viruses that 
cause persistent/chronic infections up-regulate aberrant levels of IL-10 in the host to 
dampen the antigen-specific adaptive responses, thus leading to failure of the subsequent 
viral clearance (16). Since PRRSV is a persistent virus with immunosuppressive 
properties in infected pigs, previous studies had speculated that IL-10 may have a key 
role in the suppression of immune responses by PRRSV and subsequent establishment of 
persistence in the host (72). Subsequently, several authors reported that PRRSV indeed 
up-regulates IL-10 levels both at mRNA and at protein levels under in vitro conditions 
and in vivo in infected pigs (22, 30, 55, 92, 171). In those studies, the temporal kinetics of 
PRRSV-mediated induction of IL-10 was found to be strongly associated with the 
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viremic period during the acute phase of infection but not throughout persistence. In 
contrast to above findings, one study showed that some PRRSV European strains do not 
up-regulate IL-10 levels in infected antigen presenting cells (Diaz et al., 2008). A most 
recent study involving additional strains of PRRSV has also shown that several of them 
do not up-regulate IL-10 levels in infected macrophages (154). Hence, there are 
perceptions that the ability of PRRSV to induce IL-10 in infected cells would be strain-
dependent. The correlation between the ability of a particular PRRSV strain to induce IL-
10 in infected pigs and its in vivo virulence is still not well understood. However, one 
previous study showed that the IL-10 levels during PRRSV infection is not correlated 
with the infection status of animals, and it may not be the cause of PRRS viral persistence 
(84). It seems logical that an association between the virulent character of PRRSV strains 
and their ability (or lack thereof) to induce IL-10 should be studied, using strains of bona 
fide pathogenic profile.  
Our laboratories have developed an infectious full-length cDNA (FL12) derived 
from a highly pathogenic strain of type II PRRSV. By transcription from this infectious 
clone, a PRRSV strain (vFL12) was obtained (78, 178, 204) The in vivo virulence of 
vFL12 strain has also been well characterized in the highly reproducible pregnant female 
model where vFL12 strain consistently causes reproductive failure in pregnant sows (88, 
89) and produces respiratory illness and pathology in infected young pigs (unpublished 
observations). Likewise the kinetics of immune response induced by vFL12 strain of 
PRRSV in several other studies has been shown typically dysfunctional as described for 
PRRSV: including delayed as well as poor neutralization antibody responses (5) and poor 
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innate immune responses (10, 164). Hence, it can be concluded that vFL12 is one of the 
prototypical pathogenic PRRSV strains inducing poor immune responses during disease 
process.  
We were interested in looking into whether vFL12 induces IL-10 levels in 
infected cells as well as in infected tissues in a way that would correlate with in vivo 
virulence. Unexpectedly, we found that vFL12 strain did not up-regulate IL-10 levels in 
in vitro infected cells as well as in vivo, as evidenced by sequential immunofluorescence 
staining of PRRSV (vFL12) infected tissues at different time points after infection. Hence, 
this study would attempt to shed light on an important question: Whether PRRSV 
virulent strains are really exploiting the IL-10 pathway to produce virulence in the 
infected host. The possible mechanisms of IL-10 induction by certain strains of PRRSV 
are discussed in this paper. 
MATERIALS AND METHODS 
Derivation of monocyte-derived macrophages and monocyte-derived dendritic cells 
in vitro 
Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient 
centrifugation using lymphocyte separation medium (Mediatech, Inc). The isolated 
PBMCs were incubated with Dulbecco’s modified eagle medium supplemented with 10% 
fetal bovine serum (FBS) in a glass petri-dish overnight to allow adherence of monocytes. 
The non-adherent lymphocytes were extensively washed away using sterile phosphate 
buffered saline (PBS). The adherent monocytes were then incubated with RPMI-1640 
supplemented with: 25mM HEPES, 1mM sodium pyruvate, 1X non-essential amino acids, 
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10µg/mL gentamicin and the essential growth factor(s). For the differentiation of 
macrophages, macrophage-colony stimulating factor (M-CSF) (5ng/mL) was added in the 
RPMI-1640 growth medium and further incubated for seven days. For the differentiation 
of dendritic cells, granulocyte-monocyte-colony stimulating factor (GM-CSF) (20ng/mL) 
and interleukin-4 (IL-4) (20ng/mL) were added to RPMI-1640 growth medium and 
incubated for five days. In dendritic cells culture, half of the medium was changed with 
fresh medium supplemented with GM-CSF and IL-4. After appropriate incubation period, 
the cells were harvested using Hank’s salt solution-based cell dissociation buffer 
(Invitrogen).  
Flow cytometry analysis of surface markers 
Harvested macrophage/dendritic cell cultures were analyzed for surface markers 
expression by flow cytometric analysis.  Cells were washed with flow cytometry (FCM) 
buffer (Phosphate buffered saline (Calcium and Magnesium Free) pH 7.4, 2% FBS, and 
0.1% Sodium azide). Viable cells were counted after staining with trypan blue (0.4%).  
Cells were resuspended in FCM buffer at a concentration of 5 x 10
7
 cells/mL. Cells (100 
µL) were then incubated with primary antibody (mouse anti-SWC3 or anti-MHC-II or 
anti-CD163 or anti-CD1, VMRD, Inc) at a concentration of 15µg/mL for 45 min. Cells 
were then washed twice with 1 mL of FCM buffer by centrifugation at 250 x g for 5 min 
and incubated with goat anti-mouse IgG conjugated with Alexafluor 488 (Invitrogen) at a 
dilution of 1:200 for 30 min in the dark. Subsequently, cells were washed twice with 0.5 
mL of FCM buffer by centrifugation for 5 min. Finally, cells were resuspended in 1% 
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paraformaldehyde in PBS and stored at 4
○
C until flow cytometry analysis with a 
FACScan flow cytometer (BD Biosciences). 
Viral infections, quantitative PCR, and ELISA  
Both macrophages and dendritic cells were infected with PRRSV-vFL12 at an 
m.o.i. of one. The cells were incubated with virus for 1 h at 37
○
C. Cell pellet and 
supernatant samples were collected every 12 h post-infection. Total RNAs were isolated 
using Trizol-LS reagent (Invitrogen). Approximately 1-2 µg of RNA was reverse-
transcribed using MMLV-RT (Invitrogen) to synthesize complementary DNAs (cDNAs). 
cDNAs were used as templates for PCR amplication of IL-10 or β-actin transcripts in 
each sample. The PCR primers and probes used in this study were as follows: IL-10 
(GenBank Accession No. L20001): forward primer ACTTGTTGCTGACCGGGTCT, 
reverse primer CGGCATTACGTCTTCCAGGT, Taqman probe ACCTGGGTTGCCAA 
GCCTTGTCAG; -actin (GenBank Accession No. U07786): forward primer 
CTCCTTCCTGGGCATGGA, reverse primer CCACGTCGCACTTCATGATC, Taqman 
probe TGCGGCATCCACGAGACCACCT. The optimized concentrations for primers 
and probes were as follows:  300nM each IL-10 primer, 900nM each -actin primer, and 
250nM each probe (both IL-10 and -actin). Taqman probes were dually labeled with 
FAM at 5’ end and TAMRA quencher at the 3’ end. The real time PCR was performed 
using Fast start PCR master mix (Roche Applied Sciences) in 25µL volume. The thermal 
set up consisted of initial denaturation at 95°C for 10 min; followed by denaturation at 
95°C for 15 sec, and primer extension at 60°C for 1 min for a total of 40 cycles. The 
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resulting ∆Ct values were used to interpolate the mRNA copy numbers using a standard 
curve generated from specific PCR products as template. The relative mRNA copy 
numbers were calculated as previously described (163). The secreted levels of IL-10 in 
supernatants were measured using a commercially available ELISA kit for swine IL-10 
(Biosource). Virus in the supernatant was titrated using MARC-145 cells and tissue 
culture infectivity dose 50 (TCID50) was calculated using the Reed and Muench method 
(140). 
In vivo pig infections, fixation and indirect immunofluorescence of tissue sections 
 Six PRRSV-negative weaned pigs (approximately 4 weeks-old, white Yorkshire 
crossbred) were assigned into two groups of three animals each. One group was infected 
with PRRSV-vFL12 strain at a dose of 2 x 10
5.2
 TCID50/2mL intra-nasal and intra-
muscular routes using half of dose at each route. One animal from each group was 
euthanized at 4, 7 and 11 days post-infection (dpi). Lungs, tonsils and mandibular lymph 
nodes were collected. The microtome-produced tissue sections were prepared on slides 
following adaptations of previously published procedures (9, 57). Briefly, 2-3mm thick 
tissue sections were fixed in B*5 fixative (0.6% ZnCl in 0.1% sodium acetate buffer, 
American MasterTech) for approximately 24-48 h at room temperature (RT). Tissue 
sections were gradually dehydrated at RT for 2 h each in 50% ethanol, 70% ethanol, 95% 
ethanol and finally in 100% isopropanol. The sections were cleared in xylene for 1 h with 
two changes, 30 min each at RT and infiltrated with paraffin at 58
○
C for three changes 
with 10 min each. Tissues were embedded in paraffin immediately. 3-5µm sections were 
cut sequentially by microtome and collected on microscopic slides.  
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Paraffinized tissue sections on slides were deparaffinized in xylene three changes, 
30 sec each. Subsequently, xylene was removed by washing twice with 100% ethanol, 30 
sec each. The tissue sections were gradually rehydrated at RT in 90%, 80% and 70% 
ethanol, 30 sec each. Finally, the sections were rehydrated completely with PBS and were 
further incubated with 5% DMSO in PBS for 10 min at RT. Sections were incubated with 
10% normal donkey serum and 3% bovine serum albumin in PBS-tween 20 (0.1%) to 
block non-specific protein binding for 45 min at RT. They were further incubated with 
goat anti-swine IL-10 polyclonal antibody (1:100 dilutions, R&D systems) and anti-
PRRSV murine monoclonal antibody (1:100 dilutions, USDA) for overnight at 4
○
C. 
After washing with PBS-tween 20 (0.1%) for 5 min thrice, sections were then incubated 
with donkey Alexafluor 568-conjugated anti-mouse IgG (1:100 dilutions) and donkey 
Alexafluor 488-conjugated anti-goat IgG (1:200 dilutions) for 30 min at RT. Sections 
were washed with PBS-tween 20 (0.1%) for 5 min thrice. After incubating with DAPI 
(final concentration, 250ng/mL) for 5 min, the sections were washed with PBS for 5 min 
twice. Sections were mounted using aqueous gel permanent mounting medium (DAKO) 
and examined under confocal laser scanning microscope (CLSM) (Olympus IX 81, 
Inverted Confocal Microscope) at 405nm (for DAPI), 488nm (for Alexafluor 488) and 
543nm (for Alexafluor 568) excitation laser filters. All images were taken with 60X 
magnification with the same settings in sequential mode. The pigs used in this experiment 
were confirmed negative for PCV2 viremia by PCV2-specific PCR in serum samples.  
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RESULTS 
Phenotypic characterization of swine macrophages and dendritic cells 
In order to study the IL-10 induction by PRRSV, macrophages and dendritic cells 
were established in vitro from glass adherent PBMC-derived monocytes. The 
differentiated macrophages and dendritic cells have typical morphology of respective 
cells as indicated by features such as pseudopodia, lamellipodia for macrophages and 
dendritic appearance for dendritic cells (data not shown). The surface expression of 
various markers specific for these myeloid cells was analyzed by flow cytometric 
analysis. Both cell populations expressed myeloid marker, SWC3 in approximately 97% 
of cells (Fig 1). Differentiation of myeloid cells from monocytes up-regulates surface 
MHC-II expression. Monocyte-derived macrophages consisted of two sub-populations 
based on the amount of surface MHC-II expression, corresponding to low and medium 
levels (Fig 1). However, as previously reported (190), monocyte-derived dendritic cells 
expressed high levels of MHC-II on the surface (Fig 1). Moreover, approximately 80% of 
cells among macrophage population expressed high levels of CD163 (Fig 1), which is 
highly expressed in differentiated macrophages but weakly on monocytes (149). On the 
other hand, approximately 70% of monocyte-derived dendritic cells expressed dendritic 
cell marker, CD1 (Fig 1).  
PRRSV-vFL12 strain did not up-regulate IL-10 levels in infected macrophages and 
dendritic cells in vitro 
Several (contrasting) previous reports have concluded that IL-10 expression is 
PRRSV strain-dependent. As it had been suggested that IL-10 induction might imply an 
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evasion role in PRRSV pathogenesis, we were interested in assessing the levels of IL-10 
in response to a virulent strain of PRRSV (our infectious clone-derived, vFL12) (178). To 
determine the levels of IL-10 mRNA and secreted IL-10 during vFL12 infection, 
monocyte-derived macrophages were infected with PRRSV vFL12 at an m. o. i. of 1. At 
various time points after infection, IL-10 transcripts were quantified by quantitative PCR. 
Simultaneously, IL-10 protein levels and viral titer were measured in the supernatants. As 
shown in Fig 2, there was no significant up-regulation of IL-10 mRNA levels (Fig 2a) or 
protein levels (Fig 2b) in vFL12 infected macrophages at any of the time points observed 
after infection. However, LPS-stimulated cells induced a stronger IL-10 response which 
showed a peak at 12 h after infection. The kinetics of viral replication in these cells 
showed a peak viral titer at 36 h after infection (Fig 2c). Even though these macrophages 
are capable of inducing IL-10 in response to LPS, they fail to up-regulate IL-10 at mRNA 
and protein levels during vFL12 infection. 
In order to confirm these results, we also repeated the experiments in monocyte-
derived dendritic cells. In contrast to PRRSV-infected macrophages, monocyte-derived 
dendritic cells induced IL-10 transcripts (about 10 fold), when infected with PRRSV, 
which peaked at 24 h post-infection (Fig 3a). However, there were barely detectable 
levels of IL-10 protein released in supernatants of infected dendritic cells (Fig.3b). LPS-
stimulated dendritic cells showed stronger IL-10 response than LPS-stimulated 
macrophages (Fig 2a, 2b, 3a, and 3b). From these experiments, we concluded that 
PRRSV strain vFL12 did not stimulate secretion of IL-10 in infected macrophages and 
dendritic cells grown under in vitro conditions.  
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PRRSV-vFL12 strain did not up-regulate IL-10 in infected or bystander cells in vivo 
IL-10 levels can also be up-regulated in bystander immune cells such as T-cells 
and B-cells of swine during in vivo infection by porcine circovirus (47). Even though 
PRRSV vFL12 strain did not up-regulate IL-10 in infected macrophages, it might still 
possibly up-regulate IL-10 in bystander immune cells such as T cells or B cells in 
infected tissues during in vivo infection. This was examined by immunofluorescence 
staining of PRRSV-infected tissues using swine IL-10-specific antibody. The IL-10 
staining was detected only in tonsils but not in lungs or mandibular lymph nodes after 
B*5 fixation. In both control and infected tissue sections, IL-10 positive cells were 
sporadically detected throughout the sections (shown in inset, Fig 4) suggestive of 
cytoplasmic localization of IL-10 signals (Fig 4). PRRSV-specific signals were localized 
mostly in cytoplasm of cells in all PRRSV-infected tonsils (Fig 4). They were observed 
in the area between tonsillar cryptae and T cell-rich area. Mock-infected control slides at 
all time points were scored negative for PRRSV staining. The differences in the intensity 
of PRRSV-specific staining between different time points after infection may be 
attributed to the differences in the level of fixation. The PRRSV-specific signals did not 
co-localize with IL-10 staining at cellular level in tonsils of infected animals at 7 and 10 
dpi. However, PRRSV-infected cells showed a very weak positive IL-10 staining only at 
4 dpi (Fig 4). Overall, the data suggested that PRRSV did not induce IL-10 response in 
infected cells or bystander cells in tonsils of infected animals.  
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DISCUSSION 
In this study, we report that a well characterized virulent strain of PRRSV, vFL12, 
failed to up-regulate IL-10 levels in infected cells or in bystander cells both in vitro and 
in vivo. These findings suggested that IL-10 does not appear to contribute to the virulence 
of PRRSV. Our findings were congruent with a previous report that showed IL-10 levels 
in pigs are not associated with virulent or avirulent PRRSV infections (Klinge et al., 
2009). PRRSV vFL12 strain was previously shown to actively suppress immune 
responses during infection (10). We propose that the ability of PRRSV strains to induce 
IL-10 may be indirectly mediated through the induction of one or more pro-inflammatory 
(PI) cytokines such as TNF-α, IL-1, and IL-12 during the acute phase of infection, since 
all these PI cytokines would lead to the induction of IL-10 (35, 56). Several studies have 
shown that many PRRSV strains induce IL-10 transcripts and protein levels in infected 
tissues, specifically in association with the acute phase of disease (22, 30, 45, 92, 171). 
This suggests that PRRSV has an ability to induce IL-10 during active replication in 
viremic phase in vivo. However, in our study, a virulent strain of PRRSV-vFL12 was 
unable to induce any detectable level of IL-10 in the supernatant of infected macrophages 
and dendritic cells. This clearly suggests that pathogenic vFL12 strain would not exploit 
the IL-10 induction pathway in infected myeloid cells to suppress active innate and 
adaptive immune responses. There were differences in DC populations in their ability to 
induce IL-10 in response to PRRSV infection (Hernandez et al., 2006). It is possible that 
PRRSV-vFL12 may differentially regulate IL-10 expression in different DC populations. 
However, our in vivo results showed that there were no IL-10 positive cells observed in 
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infected tonsil tissues, where mixed DC populations are present (Polak et al., 2008). 
Hence, it is more likely that PRRSV-vFL12 may not induce IL-10 in a cell type specific 
manner.  
Temporarily induced IL-10, along with many PI cytokines, is generally seen as 
beneficial to the host as it would help to suppress or mitigate the immunopathogenesis 
caused by PI cytokines (54). Previous studies have shown the occurrence of up-regulation 
of PI cytokines such as IL-12 (30, 61), IL-1 (92) and TNF-α (71) in PRRSV-infected 
animals. Such effect could potentially explain the up-regulated IL-10 levels that were 
observed in those studies. In support of our observation, recent studies also reported that 
several European and a few North American PRRSV strains lack the capacity of up-
regulating IL-10 in infected macrophages or dendritic cells (71, 154, 190). While vFL12 
strain poorly induces TNF-α and IFN-α (10, 164), its ability to induce other PI cytokines 
such as IL-1 and IL-12 remains to be studied. It is plausible that the failure of induction 
of IL-10 in vFL12-infected macrophages or dendritic cells may be associated with the 
poor induction of PI cytokines by vFL12 in those cells.  
A strong IL-10 staining in tissues should be expected in case of viral infections 
that would exploit IL-10-induction pathway (47). During in vivo infection with vFL12, 
strong PRRSV-positive cells were observed at all time points after infection in tonsils, 
which were located between the tonsillar cryptae and T cell area. These PRRSV-positive 
cells did not co-localize with IL-10 positive cells observed in the infected tissues. There 
were no differences in the number and distribution of sporadically-present IL-10-positive 
cells between control and infected tissues indicate that vFL12 does not induce IL-10 in 
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bystander cells such as T cells or non-infected macrophages. It will be interesting to see 
whether the same infected tissues would show positive signals for any PI cytokines which 
we have not explained in our studies.  
Overall, it may be concluded that a highly pathogenic PRRSV strain such as 
vFL12 does not need to exploit IL-10 induction to evade surveillance in the infected host. 
It may further be suggested that the induction of IL-10 by other PRRSV strains in several 
studies from other laboratories may be associated with their ability to induce PI cytokines 
during the acute phase of infection. In future studies, it may be appropriate to check the 
levels of different PI cytokines simultaneously with IL-10 during infection with various 
PRRSV strains.  
ACKNOWLEDGEMENTS 
This work was supported by grants received from the U.S. Department of 
Agriculture (projects No. 2008-00903 USDA-NRICGP and 2009-01654 USDA-AFRI). 
The collection of blood from donor pigs and animal studies were conducted according to 
the protocols UNL-IACUC No.07-10-048C and UNL-IACUC No.07-09-041D 
respectively. We extend our thanks to Dr. Charles Kuszynski, University of Nebraska 
Medical Center, Omaha and Mrs. Terry Fangman, Microscopy Core Facility, University 
of Nebraska-Lincoln, for helping in flow cytometry and confocal microscopy imaging 
respectively.  
 
 
 
   112 
 
 
Figure 1. Phenotypic characterization of monocyte-derived macrophages and 
monocyte-derived dendritic cells. Harvested cells were stained with respective primary 
antibodies (15µg/mL) followed by Alexafluor 488-conjugated anti-mouse secondary 
antibodies (10µg/mL). Staining with secondary antibody only was used as background 
control. Filled histograms: Surface marker-stained cells. Empty histograms: control cells. 
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a
MFI indicates mean fluorescence intensity ± standard deviation and 
b
% of positive cells 
among gated cells ± standard deviation. 
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Figure 2. PRRSV-vFL12 strain does not up-regulate IL-10 during in vitro infection 
of monocyte-derived macrophages. (a) Measurement of IL-10 mRNAs in cells mock-
infected or infected with vFL12 or stimulated with LPS by quantitative PCR. Monocyte-
derived macrophages were infected with vFL12 strain at one m.o.i. Cells in growth 
medium were used as control cells. Cells stimulated with LPS were used as positive 
control. At various time points after infection, total RNA was isolated from cells and 
cDNAs were prepared. The copy number of IL-10 mRNA was quantified by quantitative 
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PCR using cDNAs as template and normalized with the copy number of β-actin mRNA. 
Each bar indicates the amount of IL-10 mRNA copies relative to every hundred IL-10 
mRNA copies in mock-infected cells. Mean ± standard error values are shown (n=3).  (b) 
IL-10 ELISA. IL-10 was measured in the supernatants of above cultures using swine IL-
10-specific ELISA. Each bar indicates mean ± standard error value (n=3) (c) Viral titers 
in the supernatant of above cultures infected with vFL12 were measured in MARC-145 
cells and expressed as TCID50/mL. Mean ± standard error values are shown (n=3). 
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Figure 3. PRRSV-vFL12 up-regulates IL-10 mRNAs but does not induce IL-10 
protein secretion in infected monocyte-derived dendritic cells. (a) Measurement of IL-
10 mRNA levels in mock-infected, vFL12-infected and LPS-stimulated cells. Total RNA 
was isolated, cDNAs were prepared to quantify by quantitative PCR. Each bar indicates 
the average number of IL-10 mRNA copies relative to every hundred IL-10 mRNA 
copies in mock-infected cells. Mean ± standard error values (n=3) are shown. (b) 
Measurement of secreted levels of IL-10 in the supernatant of vFL12-infected dendritic 
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cells or LPS-stimulated cells or mock-infected cells. Mean ± standard error values (n=3) 
are shown. (c) Viral titers in supernatants of vFL12-infected cultures were measured in 
MARC-145 cells and expressed as TCID50/mL. Mean ± standard error values (n=3) are 
shown. 
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Figure 4. Confocal immunofluorecence staining of PRRSV-vFL12-infected and 
mock-infected control tonsils for swine IL-10 and PRRSV nucleocapsid antigen. Pigs 
were either mock-infected or infected with vFL12 and tonsils were collected at 4, 7 and 
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11 days post-infection. Tissue sections of tonsils were prepared and stained for IL-10 
(green) and PRRSV (red) using specific antibodies. The insets of confocal images 
representing tonsil section from 11 days post-infection were enlarged for cellular details 
of staining. DAPI staining was performed to mark nucleated cells (blue).  
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CONCLUSIONS 
Porcine reproductive and respiratory syndrome virus (PRRSV) causes 
reproductive failure and respiratory illness in late-term gestational sows and growing pigs 
respectively. PRRSV primarily replicates in resident macrophages in lungs and lymphoid 
tissues. After acute replication in these tissues, PRRSV perpetuates in a persistent phase 
in lymphoid tissues. The immune response to PRRSV infection is characterized by a 
weak innate-immune response, followed by retarded and inefficient neutralizing antibody 
and cell-mediated responses. The abnormal immune responses caused by PRRSV 
infection are the consequences of multiple immune-evasion mechanisms including 
cytokine dysregulation. Particularly, PRRSV infection reduces the levels of an important 
pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α) while increasing the levels 
of the anti-inflammatory cytokine, interleukin-10 (IL-10). It seems plausible that by 
inhibiting TNF-α, PRRSV could facilitate its replication in macrophages whereas by 
inducing IL-10, it could suppress the IFN-γ-specific T cell responses. In this dissertation, 
studies were undertaken to elucidate the mechanisms by which PRRSV regulates the 
production of TNF-α and IL-10. 
Macrophages induce TNF-α in response to viral infections.  However, after 
PRRSV infection, macrophages induce negligible levels of TNF-α. In our studies, an 
infectious clone-derived PRRSV strain, vFL12 did not induce TNF-α after infection of 
monocyte-derived macrophages. In macrophage cultures, vFL12 infection reduced TNF-
α mRNA levels at early times after infection but increased the mRNA levels at later 
stages of infection. Macrophage cultures infected with vFL12 did not contain detectable 
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levels of TNF-α protein in the supernatants. Therefore, vFL12 modulated TNF-α 
production in infected macrophages via two independent mechanisms: reduction of TNF-
α mRNAs and reduction of TNF-α protein. 
TNF-α mRNA levels are regulated at the promoter in the nucleus while TNF-α 
protein levels are regulated via post-transcriptional mechanisms in the cytoplasm. To 
identify viral proteins that reduce TNF-α promoter activity, we performed TNF-α 
promoter-specific luciferase assays in cells transfected with PRRSV non-structural 
proteins (Nsps) or N protein. Nsp1α and Nsp1β reduced the activation of TNF-α 
promoter at its proximal region (from nt -194 to +58). Multiple transcription factors bind 
the proximal region of TNF-α promoter. Transcription factors ATF2-c-jun and p65/p50 
(NF-κB) bind CRE-κB3 sequence while the transcription factor Sp1 binds to proximal 
and distal Sp1-binding sequences. In transcription factor-specific luciferase assays, 
Nsp1α and Nsp1β reduced the functional activities of transcription elements, CRE-κB3 
and Sp1 respectively. Additionally, in NF-κB-specific luciferase assays, Nsp1α reduced 
NF-κB activation. On the other hand, Nsp1β reduced the trans-activation function of Sp1 
in transient Sp1-specific reporter assays. Together, Nsp1α and Nsp1β reduced the 
activities of two different transcription factors to achieve maximal decrease in TNF-α 
promoter activation. We designed an in vitro TNF-α translation assay to identify PRRSV 
proteins that regulate TNF-α protein levels via a post-transcriptional mechanism. Nsp1α 
reduced TNF-α protein levels via the post-transcriptional mechanism. Therefore, Nsp1α 
may prevent the accumulation of TNF-α protein synthesized from pre-existing mRNAs 
after PRRSV infection.  
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 Nsp1α and Nsp1β are multi-domain proteins that participate in viral transcription, 
replication and virion biogenesis. Nsp1α has 180 amino acid residues that fold into two 
domains, zinc finger domain and protease domain. Nsp1β has 203 amino acid residues 
that fold into three domains, nuclease domain, linker domain and protease domain. 
Protease domains of both proteins cleave the respective proteins from viral polyprotein, 
pp1a. However, their enzymatic activities were not necessary for reducing TNF-α 
promoter activity in transient TNF-α promoter-luciferase assays. Nevertheless, protease 
domains of Nsp1α and Nsp1β reduced the TNF-α promoter activity. In addition, the other 
two domains of Nsp1β were also important for reducing TNF-α promoter activity. At 
amino acid level, five residues (Gly90, Asn91, Arg97, Arg100, and Arg124) of Nsp1α 
protease domain were necessary for reducing TNF-α promoter activity. In contrast, 
multiple amino acid stretches in all Nsp1β domains were important for reducing TNF-α 
promoter activity.  
Mutant vFL12 strains were generated by reverse genetics with mutations in 
Nsp1α at Gly90 residue and Nsp1β at 70-74 amino acid positions. Both mutant strains 
grew with slightly slower kinetics in African green monkey kidney cells, MARC-145. 
However, under in vivo conditions, the Nsp1β mutant strain replicated in pigs with 
reduced viral titers in serum. In macrophage cultures, both mutant strains increased TNF-
α mRNA levels at early times after infection. However, only Nsp1α mutant strain 
increased TNF-α protein levels in the supernatants of the cultures. Both mutant strains 
also increased TNF-α inducible chemokines such as CCL2 and CXCL10. Moreover, 
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Nsp1α mutant virus induced higher TNF-α protein in serum of pigs after 7 days post-
infection.  
Several strains of PRRSV induced IL-10 after infection but others did not. The 
correlation between PRRSV virulence and the IL-10 levels in infected pigs was unknown. 
In this study, the virulent PRRSV-vFL12 strain did not increase IL-10 mRNAs and 
protein in macrophages after infection. However, it increased IL-10 mRNAs but not the 
protein in dendritic cells after infection. In addition, vFL12 failed to increase IL-10 
expression in tissues after infecting swine.  
The general conclusions of this dissertation can be summarized as follows:  1) 
PRRSV Nsp1α and Nsp1β reduce the TNF-α expression at mRNA and protein levels. 2) 
Nsp1α Gly90 residue and Nsp1β amino acid residues at 70-74 positions are necessary for 
reducing TNF-α expression. 3) The highly virulent PRRSV strain, vFL12 fails to increase 
IL-10 levels in cultured cells or in pigs after infection, casting doubts about the 
significance of IL-10 modulation for PRRSV virulence.  
The findings of this dissertation may be helpful to design novel prophylactic and 
therapeutic strategies for PRRSV. 
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